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ABSTRACT
Nicotinic receptors belong to the superfamily of ligand-gated ion channels. Since evidence 
was rapidly accumulating implicating the non-a subunits in ligand-binding events, we 
decided to investigate eventual contributions of the neuronal (3 subunit to these events by 
performing a series of increasingly detailed experiments on a series of chimeric p subunits. 
In the first set of experiments, we constructed a variety of chimeric p subunits consisting 
of NH2-terminal neuronal P4 sequences and COOH-terminal P2 sequences and expressed 
them with the a3 subunit in Xenopus oocytes. The results showed that (a ) two residues 
in the extracellular domain of chimeric P4*P2 subunits (108p2Phe<-*-p4Val,
110p2Ser<-*-p4Thr) account for much of the relative cytisine sensitivity; and (b) four 
extracellular residues of chimeric P4*P2 subunits (112p2Ala*-*-p4Val. 113p2Val*->p4lle and 
115p2Ser(-*-p4Arg, 116p2Tyr*-*P4Ser) account for most of the relative 
tetramethylammonium sensitivity.
Encouraged by the above results, we continued our experiments with additional chimeras 
of the p2 and p4 neuronal nicotinic subunits to locate regions that contribute to differences
between the acetylcholine dose-response relationships of a3P2 and a3p4 receptors. 
Substitutions within the first 120 residues convert the EC5o for ACh from one wild-type 
value to the other, suggesting that amino acids within the first 120 residues of p2 and the
corresponding region of p4 contribute to an agonist binding site that bridges the a  and p 
subunits in neuronal nicotinic receptors.
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Since the EC50 phenotypes caused by the (32 and p4 subunits could be due to a difference 
in gating or binding properties, we attempted to unravel this question by performing 
voltage-jump relaxations for the series of neuronal nicotinic acetylcholine receptors we 
constructed previously. The chimeric (34/(12 subunits showed a transition in the 
concentration dependence of the relaxation rate constants in the region between residues 
94 and 109, analogous to our previous observation with steady-state dose-response 
relationships. The data reinforce previous conclusions that the region between residues 
94 and 109 on the (3 subunit plays a role in binding agonist but also show that other 
regions of the receptor control gating kinetics subsequent to the binding step.
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Acetylcholine receptors exist in two classes: metabotropic (linked to a G-protein 
pathway) and ionotropic (binding site and ion channel are part of the same protein). The 
latter class can be further subdivided into muscle-like receptors (reviewed in Changeux, 
Benoit, Bessis, Cartaud, Devillers-Thiery, Fontaine, Galzi, Klarsfled. and Laufer, 1990; 
Changeux, Devillers-Thiery, Galzi, and Bertrand, 1992a; Changeux, Galzi, Devillers- 
Thiery, and Bertrand, 1992c; Changeux, 1993; Karlin, 1993) and neuronal receptors 
(reviewed in Deneris, Connolly, Rogers, and Duvoisin, 1991; Role, 1992; Sargent, 1993). 
This project will deal with the latter group of receptors.
To date, a variety of neuronal-specific nicotinic acetylcholine receptors (nAChRs) 
have been cloned and characterized (Role, 1992). Muscle receptors require two alpha, 
and one each of beta, gamma (or epsilon in adult tissues) and delta subunits to form 
functional pentameric channels. The neuronal receptors exist in a variety of forms. At 
present the list consists of eight separate genes encoding alpha-like subunits and three 
beta-like subunits mostly cloned from rodents or chicks. a2, a3 and a4 (Boulter, Evans, 
Goldman, Martin, Treco, Heinemann, and Patrick, 1986; Boulter, Connolly, Deneris, 
Goldman, Heinemann, and Patrick, 1987) require co-expression with beta subunits 
(Deneris, Connolly, Boulter, Wada, Wada, Swanson, Patrick, and Heinemann. 1988;
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Deneris, Boulter, Swanson, Patrick, and Heinemann, 1989; Duvoisin. Deneris, Patrick, 
and Heinemann, 1989) to form functional channels in Xenopus oocytes. a5, although 
present in vivo (Conroy, Vemallis, and Berg, 1992), has not been fully characterized since 
it does not form functional channels when co-injected with the beta subunits. a6 and (33’s 
functions have not been elucidated yet. a7, a8 and a.9 (Couturier, Bertrand, Matter, 
Hernandez, Bertrand, Millar, Valera, Barkas, and Ballivet, 1990; Elgoyhen, Johnson, 
Boulter, Vetter, and Heinemann, 1994) all can form homomeric channels in Xenopus 
oocytes.
These nAChRs are found in the central and peripheral nervous systems. In the 
brain, radioactive agonists have mapped nicotinic sites in the cerebral cortex, 
hypothalamus, hippocampus, interpeduncular nucleus and superior culliculus (Clarke, 
Schwartz, Paul, Pert, and Pert, 1985). Antibody staining for specific subunits has found 
(32 subunit distribution throughout the brain (Swanson, Simmons, Whiting, and Lindstrom,
1987), and a7 distribution to vary somewhat from that of (32 and correspond largely to a- 
bungarotoxin (a-Btx) sites (Britto, Hamassakibritto, Ferro, Keyser, Karten, and 
Lindstrom, 1992). Northern blots and in situ hybridization were able to map the 
distribution of several subunits within the CNS (Seguela, Wadiche, Dineley-Miller, Dani, 
and Patrick, 1993). The a4 subunit seems to be expressed strongly in many areas, <x2 and 
a3 are both expressed to a lesser degree in the rat brain (Seguela et al., 1993). The (32 
subunit is also detected strongly, overlapping largely with a4 expression (Deneris et al.,
1988). (34 expression seems to be limited to the medial habenula (Duvoisin et al., 1989),
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although low levels can be detected in many more areas (Dineley-Miller and Patrick, 
1992).
Distribution of neuronal genes at the single-cell level in peripheral nervous system 
neurons has yielded complex results. Chick El 1 sympathetic neurons express a wide 
variety of neuronal genes, including a3, a5, al and 04 (Devay, Qu, and Role, 1994). Rat 
chromaffin cells express a similar spectrum of subunits, including low levels of 02 
(Lambolez, Audinat, Bochet, Crepel, and Rossier, 1992). In individual intracardiac 
parasympathetic neurons, determined by RT-single cell PCR, the view is even messier. 
Expression appears to vary among individual neurons. Some express two subunits (e.g., 
a3 and 04), whereas others express a complex pattern of genes (e.g., a2, a3, oc4, a7 and 02 
or a3, a7, 02, 03 and 04) (Corriveau and Berg, 1993).
Pharmacologically, different combinations of subunits, when expressed in frog 
oocytes, yield unique agonist sensitivities (Luetje and Patrick, 1991) as well as 
sensitivities to neurotoxins (Luetje, Wada, Rogers, Abramson, Tsuji, Heinemann, and 
Patrick, 1990). It is perhaps surprising to note that the beta subunit appears to have as 
much effect as the alpha subunit in determining agonist potencies.
Structure-function Work
It is no exaggeration to claim that the muscle nAChR is the most-studied ligand-gated 
receptor. Neuronal genes lag behind in this study. We are fortunate however, that the
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primary sequences of these two ion channel types share a high degree of homology, 
making it possible to extend the findings of one class to the other. Examination of the 
amino acid sequence reveals the presence of three distinct domains (reviewed in Changeux 
et al., 1992a; Changeux, Devillers-Thiery, Galzi, and Revah, 1992b; Changeux et al.. 
1992c): a large extracellular NLL-terminus that comprises nearly half of the mature 
protein and contains the agonist binding site in the alpha subunit, four highly conserved 
putative transmembrane segments and an intracellular loop of uncertain function linking 
the third and fourth transmembrane regions. A large amount of work has been done on 
the first two domains; because of its difference among subunits, the intracellular loop's 
function has remained a mystery.
Extracellular Segment 
There is a large body of evidence implicating the large extracellular segment in ligand- 
binding (reviewed in Changeux et al., 1992c; Changeux, 1993). In the Torpedo alpha 
subunit, a close cousin o f the muscle subunits, at least six residues have consistently been 
labeled by affinity ligands. Three are Tyr residues, at positions 93 (Galzi. Revah. Black, 
Goeldner, Hirth, and Changeux, 1990), 190 (Dennis, Giraudat, Kotzyba-Hibert. Goeldner, 
Hirth. Chang, Lazure. Chretien, and Changeux, 1988; Abramson, Li, Culver, and Taylor,
1989) and 198 (Middleton and Cohen. 1991). A Trp residue at position 149 (Dennis et 
al., 1988) and two characteristic cysteines at positions 192 and 193 (Kao, Dwork. 
Kaldany, Silver, Wideman, Stein, and Karlin. 1984; Dennis et al.. 1988) are further
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typically labeled amino acids. All these residues are conserved in all functional muscle 
and neuronal subunits. Although similar detailed studies using affinity agents have not 
been performed with neuronal subunits, it is safe to extrapolate that all above residues 
serve an analogous function in neuronal alpha subunits.
Recent experiments with o'-tubocurarine (<7-TC), a competitive antagonist, have 
detected labeling of non-alpha subunits, suggesting that the binding site may span beyond 
the confines of the alpha subunits (Fu and Sine. 1994). It is known that neuronal beta 
subunits have a significant effect on agonist sensitivities (Luetje et al., 1991). It is unclear 
whether this effect is mediated allosterically through the alpha subunits or whether the 
beta subunits contribute bona fide residues to the agonist binding site.
Channel Structure
The second transmembrane segment M2 is now generally thought to form the ion channel 
pathway. Non-competitive inhibitors, thought to enter the pore when the channel is 
open, have labeled several residues of Torpedo M2 segments. Some of these agents 
include chlorpromazine (Giraudat, Dennis, Heidmann, Chang, and Changeux, 1986; 
Giraudat, Dennis, Heidmann, Haumont, Lederer, and Changeux. 1987; Giraudat, Galzi, 
Revah. Changeux. Haumont, and Lederer, 1989), trimethylphosphonium (Hucho. 
Oberthur, and Lottspeich, 1986) and 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine 
(TID) (White, Howard, Cohen, and Cohen, 1991; White and Cohen, 1992). Mutagenesis 
of residues in this segment has provided elegant evidence that residues in it are lining the
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pore. Imoto et al. (1988) changed charged residues flanking M2; they determined that 
mutations o f these amino acids to neutral residues changed the channel conductance 
proportionally to the reduction in negative charge (Imoto, Busch. Sakmann. Mishina, 
Konno, Nakai, Bujo, Mori, Fukuda, and Numa 1988). Changes of hydrophobic residues 
within M2 to larger or more hydrophobic amino acids decreased the conductance of larger 
cations (Villarroel, Herlitze, Witzemann, Koenen, and Sakmann, 1992) and organic cations 
(Cohen, Labarca, Czyzyk, Davidson, and Lester, 1992a; Cohen, Labarca, Davidson, and 
Lester, 1992b). The association rate of the open channel blocker QX-222 was also 
affected by mutations in M2 (Leonard, Yu, Labarca, Davidson, and Lester, 1987;
Leonard, Labarca, Chamet, Davidson, and Lester, 1988). Akabas et al. (1992) mutated 
consecutive residues in M2 to Cys and the accessibility o f the cysteines was assayed by 
applying sulfhydryl-sensitive reagents (Akabas, Stauffer, Xu. and Karlin, 1992). The 
surprising finding of this work was the accessibility o f position 248 to the reagents when 
the channel was not activated by ACh. This implies that the gate is very close to the 
cytoplasmic end of the M2 helix. However, this finding was later challenged by three- 
dimensional electron micrograph reconstructions of tubular Torpedo nAChR crystals by 
Unwin (Unwin, 1993; Unwin, 1995).
The cloning of the homooligomeric al subunit (Couturier et al., 1990; Seguela et 
al., 1993) has renewed the interest in nAChRs. Because of its nature, it was possible to 
do experiments that could not be performed on muscle subunits. The ability of making a 
single mutation that is incorporated five times in the pentamer has led to dramatic
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advances in at least three areas. Mutating a highly conserved Leu residue in the second 
transmembrane helix led to startling effects on many channel properties. The 
desensitization and half-maximal dose of activation levels were altered (Revah, Bertrand, 
Galzi, Devillers-Thiery, Mulle, Hussy, Bertrand, Ballivet and Changeux, 1991) and 
compounds that act as competitive antagonists in the wild-type al oligomer started acting 
as agonists (Bertrand, Devillers-Thiery, Revah, Galzi, Hussy, Mulle, Bertrand, Ballivet, 
and Changeux, 1992). A few select mutations within M2 led to a change in permeability 
properties of the channel from cationic to anionic (Galzi, Devillers-Thiery, Hussy, 
Bertrand, Changeux, and Bertrand, 1992). Furthermore, the modularity of the receptors 
was shown when the large extracellular NH2-terminal segment of al was deleted and 
replaced with the analogous portion of the serotonergic 5HT3 receptor (Eisele, Bertrand, 
Galzi, Devillers-Thiery, Changeux, and Bertrand, 1993). This chimeric receptor showed 
distinct ligand-binding and channel specificities.
Experimental Background
Much of the work regarding agonist-receptor interactions has focused on the alpha 
subunit of nAChRs. From the work of Luetje and Patrick (1991), we were encouraged to 
find a report highlighting the importance of heretofore largely unstudied beta subunits in 
determining agonist potencies at neuronal nAChRs. We therefore embarked in a series of 
experiments designed to further our knowledge of the exact role of the beta subunit in
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contributing to the pharmacological profiles of agonists. 32 and 34 are highly similar 
(-80% amino acid identity) yet show remarkable differences in their ability to open 
channels with different agonists when expressed along with the <x3 subunit in Xenopus 
oocytes. With a series of three sets of experiments of increasing difficulty and resolution 
we attempted to find regions of the beta subunits that were responsible for agonist 
potency differences and other effects we later determined were also affected by the type 
of beta subunit.
The first, and simplest series of experiments entailed the construction of chimeric 
beta subunits assayed by single doses of four agonists: acetylcholine (ACh), cytisine 
(CYT), tetramethylammonium (TMA), and nicotine (NIC). It can be gleaned from Fig. 1 
that these four agonists represent a varied set of chemical structures, from the “minimal” 
agonist TMA containing only a quaternary ammonium moiety, to NIC with multiple 
rings and aromatic structures. It was our belief that because of their different structures 
we might have been able to dissect in greater detail eventual amino acids that contact 
various pans of the molecules. Most of these agonists were very sensitive to the type of 
beta subunit present, with the 32 subunit having generally quite lower efficacies to these 
compounds compared to 34. The analysis of our findings are found in chapter one.
Encouraged by the results of our first series of experiments, we embarked on a set 
of more ambitious data acquisition projects designed to focus our attention on the effect 
of the native agonist (ACh) on the chimeras we constructed. Our aim was to dissect a 
wider set of parameters under a more stringent set of conditions. In order to accomplish
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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this we designed an improved data acquisition protocol (a faster perfusion system) and 
distilled information from many dose-response relations from the many beta-subunit 
chimeras we had constructed. The results from this project are found in chapter two.
Finally, to improve on our steady-state measurements from dose-response 
relations, we designed a set of experiments designed to obtain kinetic parameters from 
voltage-perturbation measurements. The results of these experiments forms the third and 
last chapter of the thesis.
Summary
Throughout our experiments we have constantly identified a region in the beta subunits 
from amino acids 94 to 120 as having a crucial role in determining all phenotypes we 
investigated. Although the most recent structural evidence appears to discount a direct 
participation of the beta subunits in sharing an agonist binding site with alpha subunits 
(Unwin, 1995), our experiments suggest that the beta subunit can in fact affect the binding 
process. The most straightforward explanations of this apparent paradox are (a) the 
agonist molecule has to contact beta-subunit residues at the “mouth” of a gorge before 
reaching the de facto binding site, thereby affecting agonist on/off rates and consequently 
the binding constant: or (b) the beta subunit allosterically alters the structure of the 
binding site. More detailed structural work is necessary to resolve these issues.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1. Structural respresentation of the agonists used in the first series of our 
experiments.
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INTRODUCTION
The recent cloning o f multiple a  and (3 subunits for neuronal nicotinic acetylcholine 
receptors (nAChRs) has enabled studies o f nAChR's formed from a variety o f a and p 
subtypes (reviewed in Deneris, Connolly, Rogers, and Duvoisin. 1991). Expression of all 
possible combinations of the a and p subtypes in Xenopus oocytes shows that both 
subunits contribute to the relative sensitivity to ganglionic stimulants and neurotoxins 
(Deneris et al., 1991; Luetje and Patrick, 1991), channel conductance and gating properties 
(Papke and Heinemann, 1991; Chamet, Labarca, Cohen, Davidson, Lester, and Pilar,
1992; Papke, Boulter, Patrick and Heinemann, 1989) of neuronal nAChRs. Receptors 
containing the P4 subtype generally give larger responses than receptors containing the P2 
subtype to ganglionic stimulants such as cytisine (CYT) and nicotine (NIC) (Leutje et al., 
1991). To localize the regions o f P4 and P2 that contribute to agonist selectivity, we 
constructed chimeras of P4 and P2 consisting of M-L-terminal sequences from P4 of 
varying length and appropriate COOH-terminal counterparts from P2. These were 
expressed in combination with a3 in Xenopus oocytes.
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METHODS
Fifteen |34»|32 chimeras were constructed using a previously described PCR method 
(Higuchi, 1990) so that they contained an NH2-terminal end from (34 and a COOH- 
terminal end from (32. For example, the arrow labeled 7 in Fig. 1 denotes the chimera 
p4(7)*(32 that contains the seven most NH2-terminal residues from (34 and the remaining 
470 COOH-terminal residues from (32. mRNA for a3 and the |3 subunits was transcribed 
in vitro (Guastella, Nelson, Nelson, Czyzyk, Keynan, Miedel, Davidson, Lester, and 
Kanner, 1990) and 18 ng of each subunit was coinjected into stage V or VI Xenopus laevis 
oocytes. The oocytes were incubated 2-7 d in a modified Barth’s solution containing 5% 
horse serum. We measured the peak current produced by bath application of 30 |iM 
acetylcholine (ACh), 30 pM cytisine (CYT), 30 pM nicotine (NIC), and 100 pM 
tetramethylammonium (TMA) at a typical holding potential of -80 mV using a 
two-electrode voltage clamp. Receptors that gave ACh responses too large for accurate 
recording at -80 mV were measured at more depolarized potentials (-70 to -20 mV). ACh 
responses o f the chimeric and wild-type (WT) receptors were typically in the 100-2.000 
nA range. The recording solution contained 96 mM NaCl. 2 mM NaOH, 1 mM MgCL, 
and 5 mM HEPES (pH 7.4). External Ca2+ was omitted to minimize the activation of the
Ca2+ activated Cl' conductance (Vemino, Amador, Luetje, Patrick, and Dani, 1992). All 
recordings were made at ambient temperature (23-25’C).
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RESULTS
The region of (J4 NH2-terminal to the first transmembrane region Ml (residues 1 to 214) 
was sufficient to confer complete |}4-like CYT (Fig. 2) and TMA (Fig. 3), but not NIC 
(Fig. 4), sensitivity on the receptors containing the chimeric (14*P2 subunits. The relative 
responses of the a302 WT to CYT, TMA, and NIC were 0.03 ± 0.01 (mean ± SD, n = 5), 
0.60 ± 0.14 (n = 5), and 0.25 ± 0.11 (n = 5); the relative responses of the a3p4 WT to 
these same agonists were 2.47 ± 0.59 (n = 7), 1.80 ± 0.47 (n = 3), and 1.36 ± 0.80 (n = 7). 
The relative responses of the ct3f34(214)«P2 chimeric receptor, which contains most of the 
putative extracellular region of [14, were 2.38 ± 0.26 (n = 2) to CYT, 1.98 ± 0.46 (n = 6) 
to TMA, and 0.81 ± 0.09 (n = 5) to NIC. Thus, the relative response of a3P4(214)»P2 to 
CYT and TMA did not differ substantially from the relative response of the a3|34 WT to 
these agonists.
Chimeras |34(105)*p2 and P4(109)*P2 differ by only one residue 
(108p4Val*-*’P2Phe); as do chimeras p4(109)«P2 and p4(l 11)*P2 (110p4Thr*-+p2Ser). These 
chimeras displayed dramatic differences in relative sensitivity to CYT when expressed 
with a3 (Fig. 2). Fig. 2 also shows that (a) all six chimeras with >111 NH2-terminal 
residues from P4 (and the remaining COOH-terminal residues from P2) displayed > 70% 
of the relative a3P4 WT response to CYT and (6) all eight chimeras with < 105 NH2- 
terminal residues from P4 displayed < 13% of the relative a3P4 WT response to CYT. The 
relative CYT response of the a3P2 WT was 1% of the relative CYT response of the cx3P4 
WT receptor. Thus, chimeric receptors containing p4 residues at 108 and 110 displayed a
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relative CYT sensitivity near that of the 04 WT while chimeric receptors containing 02 
residues at these positions displayed a relative CYT sensitivity much nearer to that of the 
02 WT.
Inclusion of two adjacent regions of 04 (112Val, 113Ile and 115Arg, 116Ser) 
dramatically increased the relative sensitivity of the chimeric receptors to TMA. Fig. 3 
shows that (a) all four chimeras with >116 NHi-terminal residues from 04 displayed > 
83% of the a304 WT relative response to TMA and (b) all eight chimeras with <111 
NFty-terminal residues from 04 displayed < 39% of the a304 WT relative response to 
TMA. The relative TMA response of the a302 WT was 33% of the relative response of 
the tx304 WT to TMA. Thus, chimeric receptors containing 04 residues at 112, 113, 115, 
and 116 displayed a relative TMA sensitivity near that of the 04 WT while chimeric 
receptors containing 02 residues at these positions displayed a relative TMA sensitivity 
much closer to that of the 02 WT.
There also appears to be a transition in the relative CYT responses, but not for 
the TMA responses from values < 0.06 for a304(7)*02 (n = 5) and <x304(12)»02 (n = 7) to 
values > 0.30 for cx304(61)»02 (n = 5) (Fig. 2). However, our data are insufficiently precise 
to localize the important region.
There was no clearly demarcated zone responsible for the relative NIC sensitivity 
of 04 (Fig. 4). However, chimeras with transitions from 04 to 02 between 9402Val/04l le 
and 12202Phe/04Gln displayed dramatic variations in the mean nicotine sensitivity when 
expressed with a3.
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DISCUSSION
Our results are consistent with previous work showing that both the a  and 3 subunits 
influence the pharmacological selectivity of the neuronal nAChR (Luetje et al., 1991) and 
that non-a subunits from Torpedo nAChRs bind cholinergic ligands (Czajkowski and 
Karlin, 1991; White and Cohen, 1988). In addition to previously noted differences 
between the sensitivity of a332 and a334 to CYT, and NIC relative to ACh (Luetje et al., 
1991), we found that a334 is more sensitive than a332 to the ganglionic stimulant TMA. 
Two lines of evidence show that the greater relative response of a334 to CYT, TMA, and 
NIC cannot be due solely to a decrease in the ACh response of a334. First, normalized to 
the NIC response, the CYT and TMA response was 0.05 and 0.42 for a332 but 1.37 and 
0.76 for cx334. Second, the present data show that distinct regions of 34 contribute to the 
relative CYT and TMA sensitivity. Nonetheless, differences in the ACh sensitivity of 
cx332 and a334 may be responsible for part of the difference between the agonist 
selectivities of the two receptors.
Our data suggest that the region of the 3 subunit that is most critical for relative 
CYT and TMA sensitivity lies in the middle of the putative extracellular NFL-terminal 
sequence. Neuronal nicotinic receptors are thought to be composed of five subunits 
(Anand, Conroy, Schoepfer, Whiting, and Lindstrom, 1991; Cooper, Couturier, and 
Ballivet, 1991). Each subunit contains four transmembrane repeats (Claudio, 1989). The 
portion of each subunit NH2-terminal to M 1 forms the bulk of the extracellular portion of 
the receptor (Claudio, 1989). The M2 transmembrane segment (Claudio, 1989) and
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possibly Ml (DiPaola, Kao, and Karlin. 1990) form the channel pore. Confirming an 
earlier report (Papke, Duvoisin, and Heinemann, 1991), we have shown that the chimeric 
receptor a3(J4(214)*P2, containing all o f the putative extracellular region NHi-terminal to 
M l, has complete p4-like relative sensitivity to CYT and to TMA.
The relative NIC response of <x3P4(214)«P2 differed from that of a3p4 and the 
results did not reveal any single area in the P4»p2 chimeras responsible for relative NIC 
sensitivity. Thus, there may be (a) several regions of the p subunit involved in NIC 
selectivity; or (b) the chimeras may cause novel structural changes in the receptor which 
interfere with NIC responses.
Previous authors (Luetje et al., 1991) suggested that the small CYT response of 
receptors containing a3p2 is due to open-channel block by CYT. However, in contrast to 
previous examples of agonist block o f the nAChR (Sine and Steinbach, 1984; Ogden and 
Colquhoun, 1985), putative block of the ACh response of a3P2 by CYT is not voltage 
dependent (Luetje et al., 1991). If the channel-block hypothesis is correct, then our 
results suggest either (a) that the open-channel blocking site for CYT is in the extracellular 
portion of a3P2 or (b) that the regions we have identified in P4*P2 chimeras affect the 
structure of the channel indirectly. A more straightforward interpretation is that CYT, 
TMA, and NIC may be more effective either (a) at binding to a3P4 than to a3p2 or (6) at 
inducing the conformational change that opens the a3P4 channel. In this case, the regions 
we identified probably influence one of these molecular events at the neuronal nAChR. 
Dose response data and agonist competition experiments will be necessary to resolve 
these questions.
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Figure 1. Aligned sequences of the NFk-terminal regions of P2 (Deneris et al., 1988) and p4 
(Duvoisin et al., 1989). Downward arrows indicate the (34 to P2 transition point of each 
chimera. Numbering is based on the P4 sequence. Outlines denote identical residues. 
Shading denotes homologous residues.









R L A N
E Q I M T 1 N DYRL
E Q  MT T DYRL
107 100 111
K L  I R P A T N <  
N L I R P A T S S
i d U l v T v d l  
i s  i r[ l
MV SL A QL 1 SV
EL SL S QL 1 SV
K P E D F D N M K K V |3 l| 3 s  
N S S C Y E G V N  I L |njl[P|A
1H I W L P D V  
J R V W L P D  I
V L Y N N A
V L Y N N A
Y E V S F
Y E V S V
W  * I
yjslfJAvJvjsYdGsT
Y jljy V  I M R S M GS I
F W L P P A I Y K S A C K I E V K H F P F D Q Q N C T  
G W L P P A I Y K S A C K I E V K H F P F D Q Q N C T
K F
K F
02 R S W T Y D R T E  I D L V L K S D V
[34 R S W T Y P  H T E  I DN V L K S P T
A S L D D F T P S G E W D I
IN D D F T P S G E W D I
A L P G R R N I  







T Y D F I  I 
VlTYDF I I
R l R K P L F Y
R K P L F Y
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A-I4
Figure 2. Ratio of the CYT-induced current [/ (30|iM CYT)] to the ACh-induced current 
[7(30 pM ACh)] versus the number of NH2-terminal residues from P4 in the (54*p2 
chimera. Position zero and 475 (marked with open circles) correspond to the wild-type P2 
and (34 subunits, respectively. Dotted lines above and below the circles denote ± one SD. 
Sample sizes for individual data points were typically 3-8 oocytes. Inset shows the 
region with the most dramatic changes in relative CYT sensitivity in greater detail. Bars 
in inset denote ± one SD.
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Figure 3. Ratio of the TMA-induced current [I (100 (J.M TMA)] to the ACh-induced 
current [I (30nM ACh)] versus the number of NHi-terminal residues from (34.
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Figure 4. Ratio of the NIC-induced current [7(30 |iM NIC)] to the ACh-induced current 
[7(30|lM ACh)] versus the number of NHi-terminal residues from |J4.
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ABSTRACT
We constructed chimeras of the rat 02 and 04 neuronal nicotinic subunits to locate the 
regions that contribute to differences between the acetylcholine (ACh) dose-response 
relationships of the a3j32 and a304 receptors. Expressed in Xenopus oocytes, the a302 
receptor displays an EC50 for ACh -twentyfold less than the EC50 of the a304 receptor. 
The apparent Hill slope («app) of a302 is near one whereas the a304 receptor displays an 
«app near two. Substitutions within the first 120 residues convert the EC50 for ACh from 
one wild-type value to the other. Exchanging just 02:104-120 for the corresponding region 
of (34 shifts the EC50 of ACh dose-response relationship in the expected direction but does 
not completely convert the EC50 of the dose-response relationship from one wild-type 
value to the other. However, substitutions in the 02:104-120 region do account for the 
relative sensitivity of the a302 receptor to cytisine, tetramethylammonium, and ACh.
The expression of 04-like (strong) cooperativity requires an extensive region of 04 
(04:1-301). Relatively short 02 substitutions (02:104-120) can reduce cooperativity to 
02-like values. The results suggest that amino acids within the first 120 residues of 02 and 
the corresponding region of 04 contribute to an agonist binding site that bridges the a  and 
0 subunits in neuronal nicotinic receptors.
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INTRODUCTION
Both the a  and non-a subunits of the nicotinic acetylcholine receptor (nAChR) play a 
role in the activation of the receptor by agonist (reviewed in Deneris, Connolly. Rogers, 
and Duvoisin, 1991; Karlin, 1993; Papke. 1993). Although many studies show that 
agonist binds to the a  subunit (reviewed in Karlin, 1993), present opinion is divided 
about the possibility o f an agonist binding site at the a/non-a subunit interface 
(Cockcroft, Osguthorpe, Barnard, and Lunt, 1990; Karlin, 1993; Unwin. 1993). The 
evidence for an a-only binding site is that 9 A images of Torpedo nAChRs reveal a unique 
cleft within the a  subunit that could act as an agonist binding pocket (Unwin, 1993). 
However, there is no evidence that agonists actually bind within this cleft and contact 
only a-subunit residues. On the other hand, previous experiments show that (a) the 
muscle-type a  subunit (al)  binds nicotinic agonists with appreciable affinities only if it is 
complexed with a non-a subunit (Blount and Merlie, 1988) and (b) the competitive 
antagonist J-tubocurarine (cTTC) photolabels residues on the y and 5 subunits of Torpedo 
nAChRs (Pedersen and Cohen, 1990; Chiara and Cohen. 1992), which is strong evidence 
for a direct participation of the non-a subunits in an agonist binding site. However. dTC 
is a larger molecule than ACh and may not contact exactly the same residues that ACh 
does. Large quantities of purified neuronal nAChRs are not available for direct 
biochemical and structural analyses of potential agonist binding sites. We have exploited
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the fact that a332 and oc3p4 neuronal nAChRs expressed in Xenopus oocytes display 
different relative sensitivities to the ganglionic agonists, cytisine (CYT). 
tetramethylammonium (TMA), acetylcholine (ACh) and nicotine (Leutje and Patrick. 
1991; Figl, Cohen, Quick, Davidson, and Lester, 1992), and different dose-response 
relationships for ACh (Couturier, Erkman, Valera, Rungger, Bertrand. Boulter, Ballivet. 
and Bertand, 1990; Cachelin and Jaggi, 1991; Leutje, Piattoni, and Patrick, 1993; Wong, 
Mennerick, Clifford, Zorumski, and Isenberg, 1993), to locate the residues of (32 and (34 
involved in agonist activation of the receptor.
In an earlier study on coexpressed a3 and (3 subunits, we used (34*(32 chimeras. 
Extending the (34 NH2-terminal region of a chimera from residues (34:1-105 to 34:1-122 
(Fig. 1) changed the CYT/ACh and TMA/ACh response ratios from a332-like (32-like) to 
a3P4-like (P4-like) levels (Figl et al., 1992). These data suggested that 34:106-122, and the 
corresponding region of 32 (32:104-120), contributes to an agonist binding site that bridges 
the a  and non-a subunits. To test this hypothesis, we have extended the earlier studies 
with (a) more chimeric and mutated 3 subunits and (b) electrophysio logical measurements 
of the agonist dose-response relationship, which we summarize by the half-maximal 
agonist concentration (EC50) and Hill coefficient («apP)- The results show that the region 
of 34 that converts the EC50 for ACh from a 32-like to a 34-Iike value overlaps the 
previously localized region that converts the CYT/ACh response ratios of 34 NHr  
terminal chimeras from 32-like to 34-like values (Figl et al., 1992) and suggest that an 
important component of the agonist binding site lies within the first 120 residues of 32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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abstract form (Figl. Cohen. Gollub. Davidson, and Lester, 1993).
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METHODS
Construction o f the fi Chimeras and Mutants
We created chimeras between the 02 and (34 subunits by taking advantage of shared 
restriction sites in the two subunits and using the polymerase chain reaction (PCR) to 
generate overlapping cDNA fragments (Higuchi, 1990) from the two subunits. Fig. I 
shows an alignment of 02 and (34 amino-acid sequences. Most of the chimeras contained 
the NFF-terminal region from one 0 subtype joined to the succeeding COOH-terminal 
residues from the other 0 subtype (NHi-terminal chimeras). We refer to the NHj-terminal 
chimeras in the text by transition points between the two types of 0 subunits. For 
example, 02(229)*04 is a chimera containing the first 229 residues of 02 joined to residues 
232-475 of 04 (see Fig. 1). Chimeras containing internal substitutions are labelled by the 
end points of the substitution. For example, 04*02(104- 12O)*04 is a chimera in which we 
substituted 02:104-120 for residues 106-122 of the 04 subunit (these labels have been 
shortened to 02(104-120) and 02(106-122) in Fig. 7-8).
To create the 02(229)*04 and 04(231)*02 chimeras, we excised the cDNA fragments 
for residues 02:1-229 and 04:1-231 from the wild-type subunits with EcoRI and Bbsl, 
subcloned the excised fragments into the complementary restricted plasmid from the 
opposite 0 subunit, and sequenced the region around the 04/02 transition to check the final 
product. The remaining chimeras were constructed in three steps: (a) we synthesized
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two or more separate PCR fragments; (b) we annealed and amplified the PCR fragments; 
and (c) we inserted the annealed fragment into the appropriate restriction sites in the 
wild-type plasmid. We normally introduced a silent mutation into the chimera during the 
initial PCR reaction to allow us to check the final product by restriction analysis. In 
addition, all the chimeras were verified by DNA sequencing. We made point mutations 
using the Altered Sites Kit (Promega Corp., Madison, WI) and verified the mutations by 
restriction analysis and DNA sequencing. Point mutations are denoted in the text by 
subscripts that contain the single letter code for the original residue, followed by its 
position in the sequence, and the residue to which it was mutated. We synthesized 
mRNA in vitro using the MEGAscript Kit (Ambion, Austin, TX) or a previously 
published method (Guastella, Nelson, Nelson, Czyzyk, Keynan, Miedel, Davidson, 
Lester, and Kanner, 1990) and checked the size of the synthesized mRNA by agarose gel 
electrophoresis.
Oocyte Expression
Stage V-VI Xenopus oocytes were isolated as described previously (Quick and Lester, 
1994) and injected with mRNA in a stoichiometric ratio for a:(} of 2:3. The amount of 
mRNA injected (< 25 ng/subunit) was adjusted to maintain a maximum response (/max) of 
< 10 {lA at -50 mV. Prior to recording, the oocytes were incubated for 2-7 d at 18°C in a 
modified Barth's solution supplemented with 50 mg/ml gentamicin, 2.5 mM pyruvate,
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and 5% horse serum (Quick and Lester, 1994).
Electrophysiological Recordings
The oocytes were voltage-clamped at -50 mV with two, 3 M KCl-filled microelectrodes 
made from thick-walled borosilicate glass (model BF150-86-10, Sutter Instrument Co., 
Novato, CA) and an AxoClamp 2A voltage clamp (Axon Instruments, Foster City, CA). 
During the experiments, we perfused the recording chamber (-1.5 ml vol) with 98 mM 
NaCl, 1 mM MgCl2, and 5 mM HEPES (pH 7.4) at room temperature (20-24°C) at 10-20 
ml/min. We omitted Ca2+ from the recording solution because the entry of Ca2+ through 
neuronal nAChRs can activate the endogenous Ca2+-activated Cl' current of the oocyte 
(Vemino, Amador, Leutje, Patrick, and Dani, 1992).
We applied agonists to the oocytes by pinching-off the outflow of a U tube 
(Bormann, 1992) with a solenoid-activated pinch valve (Cole-Palmer, Niles. IL) under 
computer control. The time constant of the approach to a steady-state response (xon) 
was 0.4-0.5 s at slowly desensitizing agonist doses. To check the effective [agonist] 
reaching the oocyte from the U tube, we applied a slowly desensitizing dose of ACh (1 
mM) to an oocyte expressing a3P2 using the bath and U tube perfusion systems. Bath 
and U tube application of 1 mM ACh produced the same steady-state response. 
Endogenous muscarinic responses were rare and easily identified by their oscillatory 
nature and delayed onset after agonist application from the U tube. We did not use
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oocytes exhibiting muscarinic responses.
Collection and Analysis o f the Dose-Response Data
We recorded the responses to 6-11 different agonist doses to measure the dose-response 
relationships for individual oocytes. The agonist was applied in 6 s pulses separated by a 
2-3 min rinse with control saline. The responses were filtered at 20 Hz and digitized at a 
sampling frequency of 50 Hz using an MS-DOS computer equipped with pCLAMP V5.5 
software (Axon Instruments, Foster City, CA).
We fit the dose-response data for individual oocytes to the Hill equation.
where was the peak response at agonist concentration [A], using weighted nonlinear 
least-squares regression. To reduce the interdependence of the parameters /max, EC50, and 
napp, we allowed only the /max and the EC50 to vary when fitting to the Hill equation. The 
napp was fixed at the mean slope of the Hill plots for the receptor subtype being fit. The 
«app was determined (a) from the Hill plot by linear regression of logf/peak/C/nm - /peak)] 
against Iog[agonist] where /max was the maximum observed response and (b) from the 
Iog-log plot by regression at the foot of the dose-response relationship. The correlation 
between these two measurements of the napp was 0.89 for the 26 receptor types discussed
/.
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in the text. Regression of the log-Iog slope against the corresponding Hill slope predicted 
a log-log slope of 1.1 for a Hill slope o f 1.0 and a log-log slope of 1.9 for a Hill slope of 
2.0. We preferred the estimates of the nm  from the Hill plot because (a) the slope of the 
Hill plot was based on more points per oocyte than the initial log-log slope 
measurements, (b) log-log slope measurements tend to underestimate the true «app. (c) the 
Hill plot included more data points with a higher signal/noise ratio than the initial log-log 
plot, and {d) the napp's from the Hill plot generally fit the dose-response relationship 
better than the p's from the log-log plots. The napp's reported in the text are from Hill 
slopes rather than from log-log slopes unless stated otherwise. We weighted the residuals 
by 1/V/peak for the fit to the Hill equation because the variance of 1 ^  at the high end of 
the dose-response relationship was larger than the variance of 7 ^  at the low end. 
Repeated measurements on a single oocyte showed that long-term desensitization reduced 
the 7max but did not affect the EC50 or «app.
To compare measurements of the EC50 with widely different variances, we 
transformed the ECso's to log values. Unless otherwise stated, the measurement errors 
reported in the text are standard deviations (SD's) and the SD's for the ECso's given in the 
text are for untransformed data. To construct normalized dose-response relationships for 
the receptors, we normalized the individual dose-response relationships to the fitted 7max's 
and pooled the resulting data. We then refit the Hill equation allowing only the EC50 to 
vary. The error reported for the normalized EC50 measurements is the standard error of 
estimate (SEE).
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Correction o f the Peak Response for Desensitization
Rapid desensitization reduces the peak response because some receptors desensitize 
while the [agonist] is still rising around the oocyte. We used the following three-state 
scheme (SCHEME I) to calculate depression of the peak response by rapid 
desensitization,
C - ^ > 0 —±->D,
SCHEME I
where C, O, and D are the closed, open, and desensitized states o f the receptor, kx is the 
rate constant for the [ACh] to reach a steady state around the oocyte, and k2 represents 
the rate constant for desensitization. We obtained k\ directly from the rate constant of 
the rising phase of the response with 1 fiM ACh and k2 directly from the rate constant of 
the decay of the response within the agonist pulse (in the Results section, \/k l and 1 lk2 
are termed Ton and Tdesen). The relationship between the peak amplitude of the observed 
response (/peak) and the peak amplitude of the calculated response (/ca|C) is,
h a le




f  . \ * :
* L
k .
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At high [ACh]'s, the decay of the response consisted of two exponential components. 
These components were corrected separately using Eq. 1 and then summed to obtain the 
final calculated peak response.
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RESULTS
The P Subunit Affects the Agonist Dose-Response 
Relationship
Consistent with previous data (Couturier et al.. 1990; Leutje et al., 1993; Wong et al.. 
1993), we found that the p subunit profoundly affects the sensitivity o f neuronal 
nAChRs to ACh. Expressing a3 with P2, instead of with P4, shifted the ACh 
dose-response relationship at -50 raV considerably to the left and reduced its slope (Fig. 
2). The traces in Fig. 2, A and B are typical ACh responses of a3P2 (Fig. 2 A) and a3P4 
(Fig. 2 B) from oocytes with similar maximum responses. We fit the ACh dose-response 
relationships for a3p2 and a3p4 to the Hill equation (Fig. 2 C) using the rcapp's for a3P2 and 
a3p4 determined from Hill plots of the ACh responses (Fig. 2 D). Similar to previous 
results (Couturier et al., 1990; Leutje et al., 1993; Wong et al., 1993), the EC50 for ACh 
was 11 ± 4 p.M (mean ± SD, n = 29 oocytes) for the rat a3P2 receptor and 219 ± 12 (iM 
(n = 3) for the rat a3P4 receptor. The napp for a3P2 was 1.1 ± 0.2 (n = 29) and the «app for 
a3P4 was 2.2 ±0.1 (n = 3). Fig. 2 D shows Hill plots for the two receptors. 
Measurements of the napp from the initial slope of a log-log plot of the dose-response 
relationship (where desensitization and agonist self-block are minimal) gave similar, but 
slightly smaller, napp's for a3P2 (0.9 ±0.1 , n = 11) and a3P4 (1.9 ± 0.1, n = 3). Fig. 2 E
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shows examples of the initial portions of the log(dose)-log(response) relationships for the 
two wild-tvpe receptors. The agreement of these measurements shows that the 
difference between the «app's of a3(32 and a3p4 was not due to desensitization or 
open-channel block by the agonist. Injecting equal amounts of mRNA generally gave 
much larger maximal ACh responses for a3(34 than for a3p2 (-tenfold) but we did not 
study these differences further.
The dose-response relationships of a3p2 and cx3P4 for TMA displayed differences 
comparable to, but less pronounced than, those for ACh (Fig. 3). Fig. 3, A and B show 
sample responses of a3P2 (Fig. 3 A) and a3P4 (Fig. 3 B) to TMA. Rapid desensitization 
is less pronounced for both wild-type receptors with TMA as the agonist. The EC50 of 
a3p2 for TMA (76 ± 11 p.M, n = 7) was fivefold smaller than that of a3p4 (424 ± 94 |iM, 
n = 6 ) and the napp of a3P2 for TMA (1.4 ± 0.1, n = 7) determined from Hill plots o f the 
dose-response data was significantly smaller than the «app of a3P4 (2.0 ± 0.2, n = 6 ). As 
with ACh, the p2 subunit shifts the TMA dose-response considerably to the left (Fig. 3 
C). Thus, the p subunit affects the activation of neuronal nAChRs by an agonist that 
contains only the quaternary ammonium portion of the ACh molecule; and the effects of 
the p subunit on the agonist dose-response relationship persist even with an agonist that 
desensitizes the receptor more slowly than ACh.
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Rapid Desensitization Fails to Account for 
Differences in the EC50’s o f a3p2 and a3p4
The response of a332 to ACh (Fig. 2 A) desensitized more quickly than the response of 
a3|34 to ACh (Fig. 2 B). The time constant ton for activation of the a3p2 response to 1 
HM ACh to reach a steady-state was 0.4-0.5 s. The time constant xdesen for the 
desensitization of the a3P2 response decreased from 5-7 s at 3 (iM ACh to 0.6-0.8  s at 
300 (iM ACh. Desensitization of the a3P2 response to 300 |iM ACh was biphasic with 
an additional slow time constant of 5-6 s. The a3P4 receptor displayed little 
desensitization during the 6 s agonist pulse. The Tdesen for a3p4 was 5-6 s at 1-2 mM 
ACh and was too slow to measure at 20-500 mM ACh.
We corrected the peak ACh response of the wild-type receptors for apparent 
desensitization (see Methods) and fit the corrected data to the Hill equation to determine 
how much of the difference in the ECso’s could be due to a difference in the rate of 
desensitization. Correcting the peak response of a3P2 for apparent desensitization left 
«app unchanged but increased the EC50 of a3P2 for ACh twofold. Desensitization of a3 p4  
did not significantly affect the ACh dose-response relationship. Thus, allowing for the 
potential effects of desensitization, the EC50 of a3P4 for ACh was still tenfold larger than 
the EC50 of a3P2. The differences in desensitization accounted for such a small fraction of 
the differences between the EC50's of the wild-type receptors that we decided not to
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attempt to correct the amplitudes of the peak responses. We were unable to resolve 
desensitization occurring on a time scale faster than 1 s (Maconochie and Knight. 1992) 
using our drug application system (see Methods). Such desensitization would produce an 
apparent decrease in the EC50 of the dose-response relationship in our experiments.
NH^-terminal Substitutions o f 105 or More Residues 
Increase the EC5o for ACh
Substitutions o f 94 or fewer (34 residues had only small effects on the EC50 for ACh (Fig.
4 A); the EC50's of the cx3p4(16)*p2, a3|34(81)»P2, and a3P4(94)»p2 chimeras for ACh (13-18 
(iM) were within a factor of two of the EC50 of a3P2 for ACh. However, if the P4 NH2- 
terminal region of the chimeras was extended from 94 to 109 residues, the EC 50 for ACh 
increased dramatically to a P4-like value. Fig. 4 B presents data for the interesting region 
between residues P4:94 and P4:109 and shows the rightward shift of the normalized ACh 
dose-response relationships as more p4 residues are included. All the p4 NH2-terminal 
chimeras with 113 or more P4 NH2-terminal residues displayed P4-Iike ECso's for ACh 
(more than tenfold larger than that of a3P2). Thus, the P4/p2 residue substitutions 
necessary for P4-Iike ACh sensitivity in the P4*P2 chimeras lie in the first 113 residues of 
(34.
There are only two P4/P2 residue substitutions in P4:95-109 (see Fig. 1). The 
addition of these two substitutions increased the ECS0 of the P4 NH2-terminal chimeras
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from p2-like to P4-Iike levels. Therefore, we made the site-directed mutations P 2 M io it .f io 6v  
to change just these residues in the B2 subunit. The EC50 of the mutated receptor for ACh 
(19 ± 4 (iM, n = 5) was within a factor of two of the value for a3P2 (11 ± 4 flM). Thus, 
the increase in the EC50 of a3P4(109)»P2 over the EC50 of a3P4(94)*p2 depended on residue 
substitutions within the first 94 residues of P4 in addition to the two substitutions 
P2:Metl01+->p4:Thrl03 and p2:Phel06-‘-*-p4:Vall08. Previous experiments (Chiara et al.. 
1992; O'Leary, Filatov, and White, 1994) also suggest that a tryptophan (y:Trp55, 
5:Trp57) in the first 60 residues of the non-a subunits contributes to the agonist binding 
sites o f the Torpedo nAChR.
We also made the mutation o3P4(61)S28n*P2 to determine if the loss of a potential 
glycosylation site at P2:Asn26 was responsible for the slight decrease in the EC50 of 
a3P4(61)»P2 below that of a3p2. The ECS0 (6  ± 3 pM, n = 4) and nm  (0.8 ± 0.1, n = 4) of 
a3P4(61)s28N*P2 for ACh were not significantly different from the EC50 (5 ± 1 pM. n = 6 ) 
and the p (1.0 ± 0.1, n = 6 ) o f a3P4(61)»p2. Thus, the removal of a potential 
glycosylation site at P2:Asn26 was not responsible for the effect of a3P4(61 )»P2 on the 
EC50 for ACh.
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Increasing the napp to /34-like Values Requires an 
Extensive Region of fi4
The nm  o f the P4»P2 chimeras showed a more gradual dependence on the P4/P2 transition 
point than the EC50. The p's of these chimeras fell into three categories, [32-like («app = 
1.0-1.2), intermediate (napp = 1.6), and (34-like (nm  = 2.0-2.2). The chimeras containing 
109 or less (14 NH2-terminaI residues exhibited (12-Iike n^p's; the chimeras containing 
109-231 P4 NH2-terminal residues exhibited intermediate n ^ 's  except for a3P4(122)*P2 
(«app = 1-2 ± 0.2, n = 2); and the chimeras containing 301 or more (14 NH2-terminal 
residues exhibited p4-like «app's. The P 2 M io it ,f io 6v  mutation did not affect the napp for 
ACh.
We are not surprised by the differences between the regions of P4 that affect the 
EC50 and those that affect the nm . Areas of contact between the subunits outside the 
agonist binding site may affect the cooperativity of a multisubunit receptor (Koshland, 
Nemethy, and Filmer, 1966). Nevertheless, the overlap between the P4 residues that 
increase the ECso's of the P4«p2 chimeras and the residues that increases the napp from 
p2-like to intermediate values suggests that (34:106-122 and P2 :104-120 may be areas 
where the a  and p subunits contact each other. The results for the P4 NfN-terminal 
chimeras also suggest that these subunits contact each other somewhere between the end 
of the first putative transmembrane domain Ml and the initial portion of the M3-M4 
intracellular loop. However, our data do not allow us to exclude the alternative
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hypothesis that these residue substitutions produce a conformational change in the 
receptor that affects cooperativity indirectly.
Substituting p2:1-120 for the Corresponding Region o f p4 
Reduces the EC5q to a P2-Iike Value
We constructed a number of P2»P4 chimeras to determine the region of the P2 subunit 
required to reduce the EC50 of the chimeras to P2-like values (Fig. 5 A). Similar to results 
for the P4«P2 chimeras, substituting the first 120 residues of p2 for the corresponding 
region of P4 reduced the EC50 for ACh to 16 ± 8 pM (n = 3) which resembles the EC50 of 
a3P2 (11 ± 4 |iM). Fig. 5 B shows the effect of this substitution on the ACh 
dose-response relationship. Substituting the first 92 residues o f P2 also reduced the EC50 
for ACh (Fig. 5 A). Thus, residue substitutions in the first 92 regions of P2 do affect the 
sensitivity of the receptor to agonist but this effect is masked in the p4 NH2-terminal 
chimeras.
There is an anomalous member of the P2«P4 series; the EC50 of a3p2(229)»P4 for 
ACh was close to that of cx3p4 (Fig. 5 A). This anomalous EC50 does not seem to be due 
to a disruption of the agonist binding site. Previous data shows that this chimera displays 
a P2-Iike affinity’ for the irreversible competitive inhibitor, neuronal bungarotoxin (Papke, 
Duvoisin, and Heinemann, 1993), and we found that a3P2(229)*p4 exhibits a clear P2-like
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insensitivity to CYT relative to ACh (Fig. 6 ).
Thus, the results for the p4 and P2 NH2-terminal chimeras show that P2/pa 
substitutions in the first 120 residues of p2 and the first 113 residues of 04 are sufficient 
to convert the EC50 for ACh from one wild-type value to another.
Short 02 NH2-terminal Substitutions Disrupt the 
Cooperativity o f the Receptor
P2 NH2-terminal sequences of 92 or more residues reduced the p for ACh to a value 
near that of a3P2 for ACh (1.1 ± 0.2) (Fig. 5 C). Morever, a single measurement of the 
napp (1.1) for o3P2(59)*P4 from the initial portion of the log-log dose response relationship 
suggests that even substituting the first 59 residues o f P2 for the corresponding region of 
P4 may suffice to reduce the «app of the chimera to a P2-like value. Thus, as for the P4 
NH2-terminal chimeras, changes in the ECso's of the P2 NFF-terminal chimeras were not 
synchronous with changes in the «app. If the nm  is determined by areas of contact 
between the subunits, then these results suggest that an extensive region of 
subunit/subunit contacts, particularly at the NH2-terminals of the a3 and P4 subunits, are 
required for the receptor to display the strong cooperativity observed for the a3P4 
receptor. The small nm  of the a 3P2(120)*p4 raises the possibility that there may also be 
heterogeneity in the assembly of this receptor. The a3p2(92)*P4 and a3p2(229)»P4 
chimeras also display Hill coefficients that are slightly less than one.
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Exchanging Just p2:104-120 and p4:106-122 Shifts 
the EC5 0  in the Expected Direction
Mutations show that the two p4/p2 substitutions P2:Metl01<-+p4:Thrl03 and 
P2:Phel06<-*’f}4:Vall08 are not sufficient to change the EC50 of the ACh dose-response 
relationship. We therefore constructed the reciprocal chimeras a3p4»p2( 104-120)«p4 and 
a3P2«p4( 106-122)*P2 to test whether more extensive substimtions in this area could affect 
the EC50 for ACh. Exchanging P2:104-120 and P4:106-122 shifted the EC50 for ACh 
towards the opposing wild-type value (Fig. 7, A and B). Substituting P2:104-120 for the 
corresponding region of P4 reduced the EC50 for ACh to 90 ± 20 pM (n = 4), a value less 
than half that of a3P4 (219 ± 12 pM). The reciprocal substitution (P4:106-122 for the 
corresponding region of P2) increased the EC50 about threefold over the EC50 for a3p2. to 
28 ± 6 pM (n = 8). Consistent with the results for the P2 and p4 NHi-terminal chimeras, 
substituting P2:104-120 reduced the cooperativity of the chimera to 1.3 ± 0.1 (n = 4) 
while the reciprocal substitution did not significantly increase the n^p for ACh (1.3 ± 0.2, 
n = 8). Thus, eight residue substitutions in P2:104-120 and P4:106-122 (see Fig. 1) had an 
effect on the EC50 and napp for ACh that was independent of substitutions elsewhere in 
the p subunits.
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Substituting [32:104-120 Also Affects Agonist 
Selectivity
Previous data (Figl et al., 1992) show that extending the (34 region of a (34 NH2-terminal 
chimera from |34:1-105 to (34:1-122 increases the 30 (J.M CYT/30 fiM ACh (CYT/ACh) 
and 100 p.M TMA/30 (iM ACh (TMA/ACh) response ratios from (32-like to (34-like 
levels. We tested the effects of exchanging (32:104-120 and (34:106-122 to determine 
whether these regions accounted for the effects of the [34 NHi-terminal chimeras on 
agonist selectivity.
Substituting (32:104-120 for (34:106-122 reduced the CYT/ACh and TMA/ACh 
response ratios to (32-like values (Fig. 8 , A and B), but the reciprocal substitution 
(34:106-122 for (32:104-120 produced only a small increase in the CYT/ACh or TMA/ACh 
response ratios toward |34-like values. Thus, similar to the effects o f [32 substitutions on 
cooperativity, short internal substitutions reduce, but do not restore, the relative 
sensitivity of the a3[34 receptor to ganglionic agonists such as CYT and TMA. The 
structural basis for this correspondence between the effects of internal substitutions on 
agonist selectivity and cooperativity is unclear. Nonetheless, the effects of exchanging 
(34:106-122 and (32:104-120 on several measurements associated with agonist activation of 
the receptor suggest that these areas are places where the a and (3 subunits contact to form 
an agonist binding site.
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The Sole M2 Substitution Does Not Affect the ACh 
Dose-Response Relationship
Dose-response relationships for nAChRs are affected by mutations at several residues in 
the M2 transmembrane domain (reviewed in Karlin. 1993). There is a single (32/̂ 4 
substitution in the M2 region (p2:Val253-*->P4:Phe255). We made the reciprocal point 
mutations {*4f255v and P2v253f to test whether this substitution could shift the agonist 
dose-response relationship. Neither mutation significantly affected the EC50 or «app. The 
«app of oc3|i4p255v was 2.0 ±0.1 (n = 3); the p of a3p2V253F was 1.2 ± 0.1 (n = 3); the 
EC50 o f o3|34f255v was 231 ± 18 pM (n = 3); and, the EC50 of a 3P2v2S3F was 9 ± 1 pM (n
= 3)-
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DISCUSSION
The data reported in this paper describe the steady-state dose-response relations of 
chimeric and mutated (32 and (34 subunits expressed with the a3 subunit in oocytes. The 
data show that the first 120 residues of (32 and a comparable, but slightly shorter, region 
of (34 largely account for the different EC50's of the wild-type dose-response relationships. 
In the sharpest region of transition, chimeras that differ at only two residues have more 
than a tenfold difference in the EC5o. However, when we examined the corresponding 
mutant (32Mioit,fio6v it retained the EC50 of the wild-type p2 subunit. This important 
result shows that the two critical residues are interacting with other upstream residues 
during activation of the receptor. Longer substitutions in this region 0 2 :104-120 '(54:106- 
122) do affect (a) the ACh dose-response relationship and (b) the relative responses to 
several ganglionic agonists. The domains we have identified that affect the EC50 probably 
affect agonist binding and may contribute to an agonist binding site that bridges the a  and 
P subunits.
Our experiments also bear on the regions responsible for the cooperativity of the 
receptor («app)- Regions of the p subunits responsible for differences in the napp overlap 
with, but are not identical to. those responsible for differences in the EC50. The 
P2 :104-120 and P4:106-122 regions affect both measures. However, for the p4 NHi- 
terminal chimeras, the transition from p2 -like to P4-Iike cooperativity occurs more
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gradually than the transition from a 02-like to a 04-like EC50 and requires an extensive 
NH2-terminal region o f the 04 subunit. The high level o f cooperativity of a 304 is 
disrupted by short 02 substitutions. If receptor cooperativity is determined by areas of 
contact between the subunits (Koshland et al., 1966), then one of these contact regions 
appears to lie in 02:104-120 and 04:106-122.
The differences we observed between the ACh dose-response relationships of the 
a302 and a304 receptors are similar to those reported previously by Couturier et al.
(1990), Leutje et al. (1993), and Wong et al. (1993) but differ substantially from those 
reported by Cachelin et al. (1991). Cachelin et al. (1991) report a much smaller value for 
the EC50 o f a304 for ACh (30 ^tM) and a much larger value for the EC50 of a302 for ACh 
(354 |iM). They report similar, but less diverse, «app's for the two receptor subtypes 
(«app = 1-4 for a302; n3pp = 1.8 for a304). The reason for this discrepancy is unclear but 
most of the previous measurements, including data from a mammalian expression system 
(Wong et al., 1993), are consistent with our data.
The cz302(229)«04 chimera is anomalous because it displays a large. 04-like E C 5 0  for 
ACh even though it includes regions of sequence that confer a 02-like EC50 in another 
chimera tested. Nonetheless, the a302(229)«04 chimera exhibits a 02-like CYT/ACh 
response ratio and a 02-Iike irreversible block by neuronal bungarotoxin (Papke et al.,
1993). Based on its agonist selectivity and affinity for neuronal bungarotoxin, we suggest 
that the large EC50 of this chimera arises from a change in the conformational states of the 
receptor that enhances the relative stability of the closed singly-liganded receptor state
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(Koshland et al., 1966) rather than from a change in the agonist binding site.
Channel Block by the Agonist Fails to Account for  
Differences in the napp
Measurements of the Hill coefficient at the foot of the dose-response relationship show 
that the differences between the rtapp's of the wild-type receptors are not due to channel 
block by the agonist because open-channel block is minimal in this region. However, 
open-channel block by the agonist could reduce the apparent EC50 of the agonist 
dose-response relationship. To assess the importance of this effect, we calculated the 
dissociation constant K\ of agonist for an open-channel blocking site that would yield a 
(32-like EC50, assuming that (a) the agonist can open all the channels (a worst-case 
analysis), (6 ) a3p2 and a3(34 display a (34-like EC50 for ACh (219 (iM) in the absence of 
channel block, and (c) the napp for a3p2 is ~1. The fractional response of the receptor 
(/peak/Zmax) under these conditions is,
^  peak   1
/  ~ , 2\9mM [ACh]
1 +  +  -  -
[ACh] K,
A K, o f 10 mM would be required to bring the EC 50 to 24 p.M. Concentration- and 
voltage-jump experiments on neuronal nAChRs in bovine chromaffin cells suggest that the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
actual dissociation constant of ACh for the channel blocking site of neuronal nAChRs is 
closer to 700-1400 }lM (Maconochie et al., 1992), or 70- to 140-fold greater than the 
value required to bring the EC50 for a3|52 to 24 pM. Moreover, with a AT, of 10 mM, the 
maximum response would occur at -50 pM ACh. Higher agonist concentrations would 
reduce the amplitude of the response, contrary to our data for a3(32 (Fig. 2 A). 
Additionally, the sole substitution in M2, which is thought to contain the binding site for 
open-channel blockers, has no effect. These results strongly suggest that agonist 
self-block does not account for the differences in the ECso's that we observed.
Residues in a Homologous Region o f yand 8 
Determine Curare Binding
Three residue substitutions in the mouse y and 5 subunits (y:Ilel lb-^SiVall 18, 
y.Tyrl 17<-*5:Thrl 19, r.Serl61-'-*’8:Lysl63) account for a tenfold increase in the affinity 
of the c c |3y  receptor over the abd receptor for the competitive antagonist 
(+)-dimethyltubocurarine (Sine, 1993). Residues 32;Ilel 18 and (J2:Phel 19 in the rat 
neuronal nicotinic receptor are homologous to y llel 16 and yTyrl 17 in the mouse 
receptor and they are in the 32:104-120 domain of the rat neuronal nicotinic receptor. 
More recent evidence (Xie, Chiara, and Cohen, 1994) shows that the competitive 
antagonist cfTC also photolabels residues yTyrl 11 and yTyrl 17 in the Torpedo nAChR 
(homologous to (32:Serl 13 and p2:Phel 19 in the rat neuronal nicotinic receptor). Thus, in
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a domain homologous to 02:104-120 in the rat neuronal nicotinic receptor, we find (a) 
residues in the Torpedo y subunit that are photolabelled by dYC and (b) residues in the 
mouse y and 5 subunits that affect competitive antagonist binding. Residues in 
02:104-120 affect the nm , the E C 5 0 ,  and agonist selectivity of neuronal nicotinic 
receptors. The proximity of residues in the muscle-type nicotinic receptors that affect 
binding and photolabelling by a competitive antagonist with those in the neuronal 
nicotinic receptor that affect the napp, the E C 5 0 ,  and agonist selectivity supports the 
hypothesis that residues 02:104-120 contribute to an a /0  ligand binding site in neuronal 
nAChRs.
Differences in Channel Gating Do Not Account for 
Differences in the Wild-type EC50
We consider a simple sequential model to suggest that differences in agonist binding, 
rather than in the rates of conformational change, are primarily responsible for the 
difference between the ECso's of a302 and a304 for ACh. This kinetic scheme (SCHEME 
II) can be summarized as follows,
K" K K SCHEME II 
nA + R ■■ f d - i C —& - > 0
where n is the Hill coefficient, A is the agonist, R is the free receptor, C is the closed
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agonist-bound receptor, O is the conducting state of the receptor, /  is an agonist-bound 
inactivated state o f the receptor, and K\-Ki are dissociation constants. At equilibrium, the 
fraction of open receptors P0 is.
According to the data of Papke and Heinemann (1991), AT2 —1.1 and 0.45, and = 10 
and 20 for a3p2 and a3p4, respectively. The point here is not the absolute values of these 
numbers, but the fact that they differ by relatively small amounts for the two receptors.
A similar conclusion is reached from our own kinetic data on voltage-jump relaxations, to 
be published separately. These differences would change the EC50 by less than twofold. 
Thus, differences in the cooperativity of binding and conformational transitions of a3P2 
and a3P4 cannot account for the twentyfold difference we observed between the EC5o's of 
the wild-type receptors for ACh. This model suggests that the wild-type dissociation 
constants for agonist binding (ATi’s) differ by more than tenfold.
Regardless of the particular kinetic model used, the differences between the mean 
open times of the a3p2 and a3P4 channels do not account for the differences in the ECso's
1 H H K-, +
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of a3P2 and a304 for ACh. The open channel lifetime is usually interpreted as the rate 
constant for leaving the open state of the channel. The long open channel lifetime of the 
primary a304 channel is 75% greater than the long open channel lifetime of the primary 
a302 channel (Papke et al., 1991). All else being equal, this difference in open channel 
lifetime would be associated with a smaller EC50 for cx304 than for a302, contrary to the 
data.
Conclusions
Our study is the first attempt to determine the regions of sequence that account for the 
differences in the complete agonist dose-response relationship produced by two naturally 
occurring subunits of a channel. Past experiments on binding of antagonists or 
open-channel blockers have pinpointed just a few residues; however, channel activation in 
response to agonists is certainly a more complex phenomenon, involving binding, 
conformational changes, and interactions between the subunits. It is therefore encouraging 
that clear trends emerge from the data. Our results emphasize the involvement of one 
region, 02:104-120, in the binding event and suggest that a broader region of sequence is 
involved in the subunit contacts and/or conformational changes that open the channel.
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Figure 1. The aligned amino acid sequences of the rat (32 and (34 neuronal nAChR subunits.
The boxes outline identical residues and the shading denotes homologous residues. 
Residue 1 begins after the termination of the leader sequences (not shown). The arrows 
above the 34 sequence point to the transitions in the 34 NHi-terminal chimeras between 
the 34 and 32 sequence. The arrows beneath the 32 sequence point to the transitions in the 
32 NH2-terminal chimeras between the 32 and 34 sequence. The numbers above (below) 
the arrows are the last residues in the 34 (32) NHi-terminal regions o f the chimeras. The 
lines beneath the 32 sequence denote the transmembrane regions M1-M4.
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Figure 2. Expressing a3 with P2, rather than with (34. reduces the EC50 and apparent Hill 
coefficient (wapp) of the ACh dose-response relationship. (A) Responses o f a3B2 to 1 -300 
|iM ACh. The numbers are the [ACh] in (iM. The square pulse above the traces is the 
duration of the application of ACh from the U tube. (B) Responses of a3P4 to 20-1000 
(iM ACh. (C) Dose-response plots for a3p2 and cc3P4. The symbols denote different 
oocytes expressing a3P2 (filled circles, open circles, filled inverted triangle, open inverted 
triangles, filled squares) or a3P4 (open squares, filled upright triangles, open upright 
triangles). The lines are fits to the Hill equation (see Methods). The ECso's and the /max's 
are 17 pM and 1863 nA (filled circles), 13 mM and 1757 nA (open circles), 15 mM and 
2056 nA (filled inverted triangles), 9 mM and 1461 nA (hollow inverted triangles). 13 
mM and 1498 nA (filled squares), 216 mM and 1944 nA (open squares), 232 mM and 
2061 nA (filled upright triangles), and 209 mM and 2100 nA (open upright triangles). 
Voltage = -50 mV. (£>) Hill plots for the peak ACh responses (/peak) of a3P2 and cx3p4.
/max is the maximum observed /peak. The symbols denote different oocytes: a3P2 (filled 
circles, hollow circles), a3p4 (filled inverted triangles, hollow inverted triangles, filled 
squares). Overlap obscures some of the data. The napp's are 0.9 (filled circles), 1.0 (open 
circles), 2.2 (filled inverted triangles), 2.3 (inverted triangles), and 2.2 (filled squares). (E) 
Log-log plots of the foot of the ACh dose-response relationship show that the slope of 
the a3p4 log dose-log response relationship is -twice that of a3P2. The symbols represent 
data from six oocytes (each oocyte is represented by a different symbol). The lines are 
regression lines fit to the log-log data. The slopes for a3p4 were 2.0 (filled circles). 2.0
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(open circles), and 1.8 (filled inverted triangle); the slopes for a3p2 were 1.1 (hollow- 
inverted triangles). 1.0 (filled squares), and 1.0 (hollow squares).
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Figure 3. Expressing a3 with £4, rather than with P2, increases the EC50 and the «app of the 
TMA dose-response relationship. (A ) Responses of a3£12 to 5-2QQ pM TMA. The 
responses are labelled with the [TMA] in pM. The square pulse above the traces shows 
the timing of the TMA application. (5) Responses of a3(}4 to 50-2000 pM TMA. (C) 
Expression with (54 shifts the TMA dose-response relationship to the right and increases 
its slope. The symbols are mean normalized responses ± SD. The EC50's of the TMA 
dose-response relationships for a3(52 and a3p4 are 75 ± 3 pM (n = 7) and 416 ± 12 pM (n 
= 6) (± standard error of estimate, ± SEE).
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Figure 4. {A) Substituting 105 or more 04 NFF-terminal residues for the corresponding 
region o f 02 increases the EC50 for ACh. The horizontal axis is the number of 04 NH?- 
terminal residues in the chimera: zero for a302 and 475 for a304. The symbols are the 
mean values for the two wild types and 14 (34*02 chimeras (n = 2-29 oocytes). Overlap 
obscures some of the data. The dashed lines are ± 1 SD. The means and SD's for the 
E C 5o's were computed from log transformed data. The vertical line denotes the beginning 
of M l. (B) The addition of two residue substitutions in the 04:95-109 sequence (see Fig.
1) shifts the ACh dose-response relationship dramatically to the right. The symbols are 
the mean normalized responses ± SD (see Methods) for a304(94)*02, a304(lO5)*02, and 
a304(lO9)*02. The lines are fits to the Hill equation (see Methods). The EC50's for ACh 
are 16 ± 1 (iM (n = 9), 60 ± 4 (iM (n = 4), and 338 ± 23 (iM (n = 6 ), respectively (± 
SEE). (Q  Substituting > 301 04 NH2-terminal residues increases the «app for ACh to >
2 .0 .
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Figure 5. (A) p2 NH2-terminal substitutions have a more complex effect on the EC5o for 
ACh than 84 Nfy-terrninal substitutions. The symbols are mean values for the two 
wild-types and five p2 NH2-terminai chimeras (n = 3-29). The dashed lines are ± SD.
The vertical line denotes the beginning of M l. (B) Substituting p2:1-120 for the 
corresponding region of P4 reduces the ECSo to a P2-Iike value. The symbols are the 
normalized responses ± SD. The lines are fits to the Hill equation. The ECS0's for 
o3P2(120)«P4 and a3P4 are 15 ± 3 p.M (n = 3) and 215 ± 8 |iM (n = 3) (± SEE). (C) 
Substituting 93 or more P2 NH2-terminal residues for the corresponding regions of P4 
reduces the /iapp for ACh to P2-like values.
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Figure 6. The a3p2(229)*p4 chimera displays a p2-like insensitivity to 30 p.M CYT 
relative to ACh. (A-D) Responses to 30 uM CYT and 30 iiM ACh at -50 mV. The 
square pulses above the traces denotes the release of agonist from the U tube.
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Figure 7. Exchanging P2:104-120 and (34:106-122 shifts the EC50 of the ACh 
dose-response relationship in the appropriate direction. (A) Substituting (32:104-120 for 
|34:106-122 shifts the ACh dose-response relationship to right of the a3P4 dose-response 
relationship. (B) Substituting P4:106-122 for p2:104-120 shifts the dose-response 
relationship to the left of the a3P2 dose-response relationship.
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Figure 8. Exchanging 02:104-120 and 04:106-122 changes the ratio of the 30 pM cytisine 
(CYT) and 30 jiM ACh responses and the ratio o f the 100 pM tetramethv I ammonium 
(TMA) and 30 p.M ACh responses. (A) Substituting 02:104-120 for 04:106-122 reduces 
the CYT/ACh response ratio to a 02-Iike value but substituting 04:106-122 for 02:104-120 
only marginally increases the CYT/ACh response ratio. The solid bars are means ± SD.
(B) Substituting 02:104-120 for 04:106-122 reduces the TMA/ACh response ratio to a 
02-like value. Substituting 04:106-122 for 02:104-120 increases the TMA/ACh response 
ratio to an intermediate value.
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ABSTRACT
We have studied voltage-jump relaxations for a series of neuronal nicotinic acetylcholine 
receptors constructed by coexpression of wild type and chimeric p4/p2 subunits with a3 
subunits in Xenopus oocytes. With acetylcholine or nicotine as agonists, wild type a3(J4 
receptors displayed five- to eightfold slower and larger voltage-jump relaxations than did 
wild type a3(32 receptors. In both cases, the relaxations could best be described by a two
exponential-component fit, each component contributing approximately equal amplitudes 
over a wide range of [ACh]. Relaxation rate constants increased with [ACh] and 
saturated at 20- to 30-fold lower concentrations for the a3p2 receptor than for the a3p4 
receptor, as observed previously for steady-state conductances. Furthermore, the 
chimeric p4/p2 subunits showed a transition in the concentration dependence of the rate
constants in the region between residues 94 and 109, analogous to our previous 
observation with steady-state conductances. However, our experiments with a series of 
p-subunit chimeras did not localize residues that govern the absolute value of the kinetic 
parameters nor identified regions responsible for the voltage sensitivity. Hill coefficients 
for the relaxations also differed from those previously measured for steady state 
responses. Relaxation kinetics were virtually unchanged when the tx3 subunit was
replaced by the a4 subunit. The data reinforce previous conclusions that the region 
between residues 94 and 109 on the p subunit plays a role in binding agonist but also
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-3
show that other regions of the receptor control gating kinetics subsequent to the binding 
step.
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INTRODUCTION
It is now generally accepted that both a  and p subunits of nicotinic acetylcholine 
receptors (nAChRs) contribute to the pharmacological profiles for agonists and 
antagonists (Luetje, Wada, Rogers, Abramson, Tsuji. Heinemann, and Patrick, 1990; 
Luetje and Patrick, 1991; Figl, Cohen, Quick, Davidson, and Lester, 1992; Papke, 
Duvoisin, and Heinemann, 1993; Wong, Mennerick. Clifford, Zorumski, and Isenberg, 
1993; reviewed in Role, 1992; Sargent, 1993). Combinations containing the (54 subunit 
seem to be generally more sensitive to agonists, irrespective o f the a  subunit in the 
heteromultimeric receptor (Luetje et al., 1991). However, there is no direct evidence that 
non-a subunits actually form an agonist binding pocket (Unwin, 1995).
At the single-channel level, parameters such as open times, burst behavior, and 
conductances also depend on the type of a/p subunit combination (Papke, Boulter, 
Patrick, and Heinemann, 1989; Papke and Heinemann, 1991; reviewed in Papke, 1993). 
Specifically, a2, a3, and a4 produce channels with varied open times and single channel 
conductances when coexpressed with p2 in Xenopus oocytes (Papke et al., 1989). The p 
subunits appear to be involved in the regulation of the acetylcholine (ACh) dissociation 
rate from the channel, as well as agonist-bound opening rates (Papke et al., 1991).
Our previous work focused on macroscopic steady-state parameters. We showed 
that extending a chimeric p subunit from 94 to 109 p4 NHi-terminal residues and
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coexpressing it with the cx3 subunit in Xenopus oocytes was sufficient (a) to restore the 
relative sensitivity to cytisine and tetramethvlammonium (TMA) (Figl et al., 1992; Figl, 
Cohen, Gollub, Davidson, and Lester, 1993) and (b) to shift the half-maximal 
concentration for channel activation (EC5o) from an a3p2 to an a3p4 value (Cohen. Figl, 
Quick, Labarca, Davidson, and Lester, 1995).
To test the role of the (3 subunit in kinetic behavior, we have turned our attention 
to voltage-jump relaxation analysis of a3(32. a3(34 and receptors containing a series of 
chimeric p subunits. We show that (a) the two wild-type receptors exhibit markedly 
different relaxation kinetics across a wide ACh concentration range, (b) nicotine and ACh 
produce remarkably similar relaxation profiles, (c) exchanging a4 fora3 and 
coexpressing it with p4 has little effect on the time constants and (d) concentration 
dependence of the relaxation rate constants implicates once again the region between 
residues 94 and 109 in p4 as crucial in the response to agonists.
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METHODS
Construction o f Chimeric ft Subunits
We used a previously published method to construct our chimeras (Cohen et al.. 1995). 
In brief, the procedure incorporates a two-step PCR protocol (Higuchi, 1990). The first 
step generated two partially overlapping DNA fragments. In the second step, the two 
pieces were combined to generate a cassette incorporating the entire NFL-terminal 
portion of 04 followed by the shortest possible segment of 02 containing a convenient 
restriction site. This cassette was cut by the appropriate restriction enzymes and ligated 
to an equivalently restricted native 02 cDNA to produce the complete chimeric cDNA. 
We checked the transition regions of the chimeras with a fluorescent dideoxy-terminator 
sequencing protocol from Applied Biosystems, Inc. (Foster City, CA).
Finally, we synthesized mRNA in vitro using the Ambion MEGAscript kit 
(Ambion Corp., Austin, TX) or a previously published method (Guastella. Nelson, 
Nelson, Czyzyk, Keynan, Miedel, Davidson, Lester, and Kanner, 1990).
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Oocyte Expression
We prepared Xenopus stage V-VI oocytes as described previously (Quick and Lester, 
1994). a  and p subunit cRNAs were injected in a stoichiometric ratio of 2:3. After 
injection we incubated the oocytes for 2-7 d at 20 °C in a modified Barth’s solution 
supplemented with 5% horse serum, 50 pg/ml gentamicin and 2.5 mM Na-pyruvate.
Electrophysiological Recordings
A detailed description of our U tube recording procedure is described elsewhere (Cohen 
et al., 1995). The recording solution consisted of 98 mM NaCl, 1 mM MgCl2 and 5 mM 
HEPES (pH 7.4); we omitted Ca2+ to prevent activation of the Ca2+-activated Cl’ channels 
(Vemino, Amador, Luetje, Patrick, and Dani, 1992).
Oocytes expressing endogenous muscarinic currents were not used in our 
experiments.
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Data Collection and Analysis
The holding potential between voltage-clamp episodes was -50 mV. The responses were 
filtered at 500 or 1000 Hz and analyzed using pCLAMP V. 6.0 software (Axon 
Instruments; Foster City, CA).
All our relaxations were fit with two exponential components. Relaxation values 
are expressed as time constants (in ms) or as the reciprocal of this value, rate constants 
(in s '1). The 1/ t values above 100 pM ACh for the a3p2 and 1000 |iM ACh for the a3p4 
for the fast components, and responses above 50 pM ACh for the a3(32 and 200 pM ACh 
for the a3p4 receptors for the slow components were not included in our dose-response 
analysis because they progressively decreased in value. Although we are unsure about 
the cause of this phenomenon, we suspect that contribution by desensitized or blocked 
states may be responsible. All data points were averaged across voltage to simplify 
comparisons. To determine ECso's and napp’s for the dose-response relations, we fit the 
data, by weighted nonlinear least-squares regression, to a modified Hill equation:
1/T 1 +(£Ci0/[A a])"” + l/r ° <U
where 1/r was the measured rate constant at agonist concentration [ACh], 1/r 0 was the 
rate constant at the low-concentration limit and was determined by extrapolation of the
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dose-response relationships to [ACh] = 0. We also fixed «app at the value that best 
approximated the shape of the curve. Thus, only ! /rniav and EC5g were left to vary. For 
the normalization procedure in Fig. 6 , we subtracted l / r 0 from 1/r and divided the result 
by l / r max.
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RESULTS
The Voltage-Jump Relaxation Procedure
This article describes in detail the voltage dependence o f a3(32 and a3(J4 receptors. We 
first describe the framework of our analyses.
Fig. 1 shows sample traces illustrating the voltage-clamp protocol used for most 
experiments in this study. The ACh concentration was 1 (iM ACh. The membrane 
potential was held at -50 mV, stepped to a prepulse value o f +50 mV, then jumped again 
to various test potentials between -150 and -50 mV in 20 mV increments. In general, we 
found that (a) the currents relaxed to more negative steady-state values with time (Fig. 1, 
A and B), implying (a) that further channels opened upon hyperpolarization; and (b) the 
relaxations were progressively larger at more negative test potentials (Fig. 1 D). Fig. 1 
also illustrates the marked difference in relaxation phenotype for the two receptors, with 
a3(J2 showing relaxations that are briefer in duration (see also Fig. 4) and smaller in 
amplitude (Fig. 1 D) than their a3p4 counterparts at equivalent ACh concentrations.
These kinetic data can be quantified in several ways. For instance. Fig. 1 B shows 
one- and two-exponential fits to the -150 mV traces in panel A. Whereas the single­
exponential fit clearly deviates from the data, the two-exponential curves superimpose on 
the traces. We noticed this behavior at all other voltages and concentrations studied.
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The total relaxation amplitude (7SS) is the sum of two components: an 
instantaneous component. /insI. and a relaxation component 7re|ax. 7mst is proportional to 
the number of channels that are “available” at the prepulse potential (in our case, +50 
mV); freiax describes the voltage-dependent opening recruitment of new channels at the 
test voltage (the preceding paragraph shows that IKiax itself consists of two distinct 
exponential components). Steady-state current-voltage (7-10 relations of neuronal 
nAChRs typically show steep inward rectification (Ifune and Steinbach, 1990b, Ifune and 
Steinbach, 1992; Sands and Barish, 1992). In order to determine which component of the 
relaxation, 7inst or 7^^, is responsible for the steady-state rectification, we plotted the 
voltage dependence of 7 ^  (Fig. 1 Q . These relations, obtained by extrapolating the 
currents to the time of the test jum p, showed only small nonlinearities; the major 
rectification in the steady-state current-voltage relations therefore arises from the 
kinetically resolvable component 7reiax .
We investigated the relative sizes of the two relaxation components. 7inst and 7reiax 
to compare the relative voltage dependence of the two receptor types. The contribution 
of the relaxations can be quantified by plotting the ratio between the instantaneous and 
steady-state values. 7ss/7inst (Fig. ID ). In general, a3(S4 relaxations are much larger than
cx3p2 relaxations, underscoring a larger voltage dependence (described below) ofa3(J4 
receptors. Average values for this parameter, from many experiments, are plotted in Fig.
7 below.
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The different voltage sensitivities o f the steady-state currents were also reflected 
by different voltage dependences of the rate constants (Fig. 2). In general, there were no 
clear voltage dependences of the rate constants for the a3p2 receptor, but the a3|34 
receptor displayed a roughly twofold change in both the fast and slow rate constants over 
the range from -70 mV to -150 mV at the exemplar ACh concentration of I (iM.
Availability
Because neuronal receptors show macroscopic inward rectification partially due to 
channel blockade by intracellular Mg2+, (Ifune and Steinbach, 1990a: Ifune and 
Steinbach, 1991; Sands et al., 1992) it was not possible to measure currents at positive 
potentials. We therefore devised a protocol to study voltage-dependent availability by 
measuring instantaneous currents just after hyperpolarizing voltage jumps from various 
prepulse potentials (Fig. 3). The data show, as expected, that the fraction of 
instantaneous current { I^ h s )  decreases at less negative potentials for both a3p2 and 
a3p4 receptors; the straightforward explanation of this effect is that fewer channels are 
open at steady state as the membrane is depolarized (Sheridan and Lester, 1977). 
Availability was quantified by fitting the data by nonlinear least-squares regression with a 
Boltzmann function:
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(2)
where Vn represents the half-maximal activation potential, is the slope factor and 
expresses the steepness of the voltage dependence and /7mm is the plateau o f availability 
at depolarized voltages. The data presented in Fig. 3 C are a composite of two separate 
experiments. These data show, again, that the a3p2 receptor is less voltage sensitive than
the a3p4 receptor: the slope factors, k^, were 27 mV and 16 mV, respectively.
Surprisingly, there is a plateau of availability for both receptors, at ~ 0.56 for the 
a3p2 receptor and -0 .17  for the a3p4 receptor, implying that in the case of oc3p2
receptors, more than half remain “available” for opening at our most positive test 
potentials. This point is treated in the Discussion.
A final point is that the availability did not depend noticeably on the duration of 
the prepulse. For the a3p2 receptors, the prepulse was varied between 50 and 400 ms; for
the a3p4 receptors, the prepulse was varied between 200 ms and 2 s. In both cases, we 
saw no significant changes in the relaxation parameters. This indicates that channel 
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Voltage-jump relaxations were also performed with nicotine as agonist (2. 10 and 50 
U.M). In general, relaxations waveforms closely resembled those for ACh; both receptors
showed voltage-dependent steady-state currents, and a3(34 currents were more voltage 
dependent than a3|32 currents. There were two exponential components, with rate 
constants -225 s ' 1 and 40 s' 1 for the a3p2 receptor and -  50 s' 1 and 5 s' 1 for the a3(i4 
receptor. These values are similar to those we observed for ACh as agonist at similar 
concentrations.
Initial Theoretical Treatment 
Because the voltage-jump relaxations will be employed throughout this study, we wish to 
provide a sketch of the theoretical background at this point. The most straightforward 
interpretations of these relaxations are that (a) channels open more frequently at more 
negative potentials, and/or (b) the channels remain open for a longer period of time. 
Although we cannot yet specify the molecular nature of the voltage-dependent rate- 
limiting gating step that gives rise to the relaxations, it is generally observed for nicotinic 
receptors that the number of channels open at more depolarized potentials decreases 
(Lester, 1992). In particular, for muscle receptors it is usually thought that a change in 
the dipole moment between the open and closed states gives rise to the voltage 
dependence (Magleby and Stevens, 1972).
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The fact that voltage-dependent availability shows a plateau at positive potentials 
has been attributed to a change in the dipole moment at these potentials (Dionne and 
Stevens 1975). However, an equally plausible hypothesis for the plateau derives from the 
well-known blockade of various neuronal nAChRs by intracellular Mg2* at positive 
potentials (Lester, 1992). In this alternative hypothesis. Mg2'  would trap the channel in a 
“blocked but open” state, prolonging the lifetime of the open state at positive potentials. 
This hypothesis gains plausibility from the fact that inwardly rectifying K+ channels 
display steady-state current relations and plateau values for availability in symmetrical 
K+ solutions that strongly resemble the present data for ACh receptors (Silver and 
DeCoursey, 1990; Doupnik, Lim, Kofuji, Davidson, and Lester, 1995). Although it is 
thought that Mg2+ blockade equilibrates within a fraction of 1 ms, it is conceivable that 
the voltage-jump relaxations also partially reflect voltage-dependent blockade by Mg2+ or 
other intracellular polycations.
Despite these uncertainties about the precise molecular nature of the voltage-jump 
relaxations, they comprise a readily quantifiable kinetic phenomenon that we can use for 
studying kinetic properties of chimeric subunits. Furthermore, the two wild-type 
receptors clearly differ in these voltage-dependent gating properties. In general, gating of 
the a3p2 receptor seems less voltage-dependent than that of the a3|34 receptor and a3p2 
relaxations are much faster than their a3p4 counterparts.
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Concentration Dependence o f Voltage-Jump Kinetics
This paper deals with the differing kinetic characteristics of the a3p2 and a3p4 receptors. 
To help study the underlying mechanism of the relaxations, we measured voltage-jump 
relaxations over a range of ACh concentrations for the a3p2 and cx3p4 receptors (Fig. 4).
There was a clear trend toward more rapid relaxations at higher [ACh], for both 
exponential components and for both receptors. We abstracted these data into the 
following parameters: zero-concentration limit l / r 0, high-concentration limit 1/ r ^ ,  
EC50, and Hill coefficient nm  (Eq. 1). The two receptors showed clearly different 
concentration dependences. For the a3p2 receptor, both the fast phase and the slow phase 
showed a plateau at [ACh] > -  10 (iM; the average EC50 values for the fast and slow 
phases were 2.3 and 3.1 |iM, respectively. For the a3p4 receptor, on the other hand, the 
average EC50 values were 67 and 58 |iM. The more rapid kinetics of the a3p2 receptor 
were reflected in the facts that (a) at equal concentrations. a3p2 relaxation profiles were 
faster than a3p4 relaxations (Fig. 4,A and B); (b) the 1/t0 values for a3p2 (10 s' 1 and 
50 s '1) were somewhat higher than the corresponding values for a3p4 (4 s' 1 and 15 s '1): 
and (c) the l / r max values for a3p2 (50 s' 1 and 316 s*1) were somewhat higher than the 
corresponding values for a3p4 (36 s' 1 and 168 s '1).
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The Hill coefficients of the a3p2 receptor were 1.7 for both fast and slow 
components and 0.8 for both components of the a3p4 receptor. Interestingly, the Hill 
coefficients for the relaxation dose-response data are roughly the opposite of the values 
we determined for the steady-state dose response relationships (nH = 1-1 for the a3p2 and 
«h = 2.0 for the a3fJ4 receptors (Cohen et al., 1995)).
There are admittedly some imprecise points in these analyses. First, we pooled 
the data across all voltages; for a3p4, in particular, the clear voitage dependences of the
relaxation time constants (Fig. 2) resulted in voltage-dependent dose-response relations. 
For instance, for the fast components, we found that EC50 was about twofold greater at 
-70 mV than at -150 mV and nm = 1.0 and 1.3, respectively. All estimates for a3p4 EC50 
exceed the corresponding a3p2 values by -  tenfold, however; and we felt that pooling the 
data across all voltages was desirable to provide a simple picture o f the results. Second, 
the relaxation rate constants tended to decrease somewhat at concentrations higher than 
those presented in Fig. 4. These declines reached a factor of two for the a3p2 receptor at 
1 mM ACh; we suspect that they arose from either desensitization or channel block and 
we did not investigate this phenomenon further.
Each relaxation had two exponential components; and our analysis provided the 
relative amplitudes of these components. Surprisingly, the amplitudes were roughly 
equal, independent of both (a) [ACh] and (b) the subunit composition of the receptor
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(Fig. 4, C and D). Thus, the global average l ^ h o i  was 0.55 + 0.06 for a302 and 
0.51 +0.10 for a304 (mean + SD, n > 30).
Another surprising result of our analysis is that the EC50 values for 1/t do not 
equal the EC50 values for steady-state responses reported in a previous study (Cohen et 
al., 1995). In general, the 1/t  EC50 values for both receptors are lower than those for the 
steady-state currents by three- to fourfold. In most straightforward relaxation theories 
that attempt to obtain equilibrium parameters by kinetics, the EC50 for 1/t  equals or 
exceeds that for equilibrium activation (Adams, 1981). Thus, there remain interesting 
questions about the molecular and mechanistic details o f ACh responses in our 
experiments. Nonetheless, the concentration dependences of the kinetic parameters 
provide a convenient set of metrics for studying the properties of chimeric subunits.
Kinetic Properties of Chimeric Subunits
We conducted kinetic experiments on the series of (54/02 subunit chimeras reported in a
previous study (Cohen et al., 1995). For convenience, the transition points of these 
chimeras are presented again here as Fig. 5. Previous results showed important effects of 
residues in the region between positions 94 and 109 when various 04/02 subunit chimeras 
were coexpressed with the a3 subunit. We therefore concentrated our efforts on chimeras 
in this crucial region.
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Fig. 6 , A and B present the concentration dependences for the voltage-jump rate 
constants with three of the chimeras that span the width of the region we recently found 
important in determining EC5o phenotypes (Cohen et al., 1995). The rate constants all 
fall within the same general range observed for the wild-type receptors: 100 to 350 s"1 for 
the fast rate constants (Fig. 6 A) and 20 to 80 s' 1 for the slow rate constants (Fig. 6 B). 
Inspection of Fig. 6 , A and B shows, however, that the rate constants for ot3(J4(94) tend to 
saturate at [ACh] > 10 |iM, whereas the rate constants for a3(J4(109) and for a3|J4(122) 
continue to increase for the highest [ACh] used in these studies, 50 (iM.
We have clarified this picture by normalizing the concentration dependences as 
follows. For each receptor, the dose-response data were fit to the modified Hill equation, 
Eq. (1) above. The zero-concentration intercepts, 1/To, were subtracted, leaving only the 
concentration-dependent parts of the dose-response relation. Next, the data were 
normalized by dividing by 1 / r ^ . These subtracted and normalized dose-response 
relations are plotted in Fig. 6 C and 6 D (fast and slow rate constants, respectively). The 
plots emphasize that the three chimeras segregate into two groups: rate constants for 
a3(J4(94) saturate within the range of concentrations tested, while rate constants for 
a3|}4(109) and for a3|54(122) do not saturate within the range studied and appear shifted 
toward higher concentrations.
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The fitted values for EC 50 quantify these impressions: For the fast components, 
a 3p4(94) had an EC50 of 1.9 pM, a334(109) an EC50 of 98 pM and a3p4(l22) an EC50 of 
190 pM. The EC 50 values for the slow rate constants were 1.0 pM for the a334(94), 250 
pM for the a334(109) and 340 pM for the a3p4(122) receptors. Thus, the EC50 values for 
the cx334(94) receptor resemble those for the wild-type a332 receptor (2.3 and 3.1 pM for 
fast and slow relaxations, respectively); whereas the values for cx3p4(109) and a334(122) 
chimeras are much greater. It must be appreciated that uncertainties attend the estimate 
of EC50 for data that show little signs of saturation, so that the EC50 for the a334(109) and
a334(122) should be considered as roughly comparable to that for the wild-type a334 
receptor.
Despite the normalizations and other data manipulations involved, our data 
clearly show the following. When we extended the 34 NH2-terminal portions from 
residue 94 to residue 109, the dose-response relation shifted rightward (Fig. 6 , A and B 
for the fast and slow relaxations, respectively). However, this rightward shift was not 
accompanied by a pronounced drop in the rate constants to a334 values (cf. Fig. 4).
These results are very similar to our observations, with steady-state measurements, that 
the dose-response relation shifts rightward by several fold for the same chimeras within 
the region 94 to 109 (Cohen et al.. 1995).
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Thus, both our steady-state and kinetic data show that a region of (34. spanning 
residues 94 to 109. is sufficient to shift the EC 50 from an a3(32 to an a3B4 value. 
Nonetheless, the absolute values of the kinetic constants themselves do not vary 
appreciably within this series of chimeras.
Neither Chimeras nor Point Mutations Localize 
Voltage Dependence or Kinetics
We comment briefly on the extensive kinetic measurements we have made with 20 other 
chimeras in the series of Fig. 5. In all cases, these chimeras displayed (a) voltage- 
dependent steady-state responses to ACh, (6) voltage-jump relaxations with two 
exponential components, and (c) rate constants for these relaxations in the range of 10 to 
400 s '1. Thus, the kinetic phenomenology for the chimeric (3 subunits falls within the 
range observed for the two wild-type subunits. However, none of the chimeras we tested 
approached the unique kinetic and steady-state signature of the wild-type a3(34 receptor: 
slow relaxation rate constants (~ 3 s '1) leading to several-fold increases in the 
conductance.
Examples of the data are shown in Fig. 7, which analyzes steady-state voltage 
dependence by plotting versus voltage for several chimeras with progressively 
longer |34 NH2-termini. Importantly, there are no major changes in voltage sensitivity
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within the series that span the range including positions 94 and 109. Therefore, the 
voltage dependence is not controlled by the same residues that control the EC50 for the 
kinetics. A partial transition to the (34 wild-type phenotype occurs for the a3(34(301) 
chimera, but its voltage dependence is still much more similar to that of the a3p2 receptor 
than to that o f the a3(34 receptor.
Given the importance of the M2 region for gating of neuronal (Revah, Bertrand, 
Galzi, Devillers-Thiery, Mulle, Hussy, Bertrand, Ballivet, and Changeux, 1991) and 
muscle (Labarca, Nowak, Zhang, Tang, Deshpande, and Lester, 1995) nAChRs, we were 
interested in examining the differences between the (32 and (34 subunits within the M2 
region. There is only one amino acid substitution (Fig. 5): (32 has a valine and (34 has a
phenylalanine residue at position 13’ (Chamet, Labarca, Leonard, Vogelaar, Czyzyk, 
Gouin, Davidson, and Lester, 1990). We constructed and tested the two appropriate point 
mutants ((32Vi3 f and P4 fi3 v) and found that the voltage-jump relaxation phenotypes for 
these mutants were unchanged from those of the respective wild-type subunits (data not 
shown).
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The Relaxation Profiles of a3(34 and a4fi4 Are 
Virtually Indistinguishable
Luetje and Patrick (Luetje et al., 1991) showed that sensitivity to agonists such as ACh, 
nicotine, cytisine and l,l-dimethyl-4-phenylpiperazinium (DMPP) was controlled by 
both the a  and p subunits. Voltage-jump relaxation experiments have previously been 
reported for a4p2 receptors expressed in oocytes (Chamet, Labarca, Cohen, Davidson, 
Lester, and Pilar, 1991); and properties are similar to those reported here for a3p2 
receptors: weak voltage dependence and relaxations on a time scale of tens of ms.
In order to determine in greater detail whether relaxation behavior depends 
strongly on the identity of the a  subunit, we substituted a4 fora3 and coexpressed it with
p4 in oocytes. We tested this combination for [ACh] in the range from 0.2 to 5 (iM. 
Voltage-jump relaxation waveforms for this combination were virtually indistinguishable 
from those for the a3p4 combination at the concentrations tested (Fig. 8 A \ both the fast
and slow rate constants for a3p4 and a4p4 are nearly identical (Fig. 8 B), at least for the
beginning of the dose-response relation. Clearly the p subunit plays a major role in 
controlling the kinetic behavior of neuronal nicotinic receptors.
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DISCUSSION
General Remarks: Role o f the Subunit
The present article describes for the first time a thorough analysis of the voltage-jump 
relaxation behavior of a3p2 and a3p4 neuronal nAChRs. We describe in detail both the 
voltage dependence of steady-state responses, the kinetics of voltage-jump relaxations, 
and the concentration dependence of these rate constants. In addition, the study 
continues our analysis of functional domains of neuronal nAChR p subunits. The present 
data complement our earlier steady-state data (Cohen et al., 1995).
We observe clear differences between the wild-type p2 and p4 subunits when 
coexpressed with the a3 subunit (Fig. 1 and Fig. 4). The a3p2 receptors display less 
voltage sensitivity, more rapid kinetics, greater sensitivity to ACh, and a greater Hill 
coefficient than the a3p4 receptors. The difference in agonist sensitivity was expected
from the steady-state data; the difference in Hill coefficient is more surprising.
Furthermore, we are again intrigued by the central role that p subunits appear to 
play in determining the characteristics of the functional pentamer since replacing the a3 
subunit, used for most of our studies, by the a4 subunit had a marginal effect on the 
relaxation phenotypes at low agonist concentrations (Fig. 8). Because voltage-jump
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relaxations at low agonist concentrations reflect primarily the burst duration, we conclude 
that the burst duration is similar for «3p4 and «4p4 receptors. We do not know whether 
the kinetics would differ at higher [ACh]; if so, this would reflect a difference in the 
frequency of bursts at a given concentration.
The M2 region of neuronal nicotinic receptors is known to be important in 
affecting gating properties (Revah et al., 1991; Bertrand. Devillers-Thiery, Revah, Galzi. 
Hussy, Mulle, Bertrand, Ballivet, and Changeux, 1992). The two (J subunits in this work 
differed by only one amino acid in M2 (P2i3-v; (34I3-F), yet this mutation was unable to 
affect any parameter of the relaxation behavior. We must therefore conclude that the 
regions that determine the voltage sensitivity of the relaxations as contributed by the two 
P subunits are outside M2.
Strikingly, the present data complement the steady-state data in showing that the 
region between positions 94 and 109 is crucial in determining how the agonist affects 
gating. The time scale of gating is not affected by varying the transition point of 
chimeras in this region; but the transition does affect the relationship between agonist 
concentration and the time scale of gating. This is a subtle combination of concepts; it 
can best be understood by referring to Fig. 4 and Fig. 7. Our molecular interpretation of 
these data follows: channels open more frequently as [ACh] increases. The relationship 
between [ACh] and the opening frequency depends on residues in the region discussed; 
but the time scale of the opening events is determined elsewhere in the receptor, as
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discussed in the following section. Our experiments do not localize the region that 
determines the time scale of channel opening: nor do they localize the region that 
determines the voltage dependence of channel gating.
Molecular Basis o f the Relaxations
To analyze the concentration dependence of the kinetics, we use a simple model similar 
to those employed for extensive voltage-jump studies of muscle nAChRs (Adams. 1975; 
Neher and Sakmann, 1975; Sheridan and Lester, 1975; Adams et al., 1980). The model 
involves a fast binding step followed by a slower conformational transition that leads to 
channel opening:
p
R &  A R d A  R *  
k _ { n a  n
fust slow
SCHEME I
where k\ and kA represent the forward and backward rate constants of binding, 
respectively; p and a  are the forward and backward rate constants for the channel- 
opening transition; n is the Hill coefficient; A is the ligand and R the receptor. This
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scheme, consisting of two transitions, predicts two relaxation rate constants. With our 
assumption that the p/a transition is slower and rate-limiting, the slower relaxation rate 
constant becomes:
1/t = a +  - ------  n)
where Kd~ k.\/k\.
According to this scheme, the zero-[ACh] limit is a; the high-[ACh] limit is a +  #  
and our estimated EC50 values equal the dissociation constants (Kd) of SCHEME I. A 
more exact model would explicitly deal with each of the n binding reactions; but for 
n < 2 , the half-maximal concentration differs by less than fourfold from Kd if k.\/k\ is 
equal for the two reactions.
It is thought that the opening rate is relatively independent of voltage; on the other 
hand, the closing rate is dependent on voltage. Single-channel recordings, however, 
reveal many types of opening and closing transitions, on times scales ranging from tens 
of |is to tens of s. The observed relaxations, on time scales of ms to hundreds of ms. are 
generally thought to arise from voltage-dependent “burst durations.” A burst is thought 
to arise from binding of a single pair of agonist molecules and to comprise a series of 
single-channel openings separated by intervals whose time scale is roughly equal to, or
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shorter than, the duration of the openings. We suggest that the present relaxations 
measure the frequency (a) and duration (1/B) of such bursts. ot3p2 bursts are several fold
briefer than a3p4 bursts, in agreement with this interpretation (Papke et al.. 1991). The
relaxations are too slow to arise directly from single-channel openings (Chamet et al..
1991; Papke et al., 1991).
Voltage-jump relaxations cannot be caused by a voltage-dependent step that is 
slower than the time scale of the relaxations; but the voltage-dependent step could be 
much faster than the time scale of the relaxations. In the Results section, we point out 
that a rapidly equilibrating, voltage-dependent open-channel blockade by Mg2+ could be 
influencing our relaxations at positive potentials.
Two Components to the Voltage-Jump Relaxations
We certainly did not begin this study attempting to find complexities in our relaxations. 
Indeed, muscle nAChR relaxations have been fit with single exponentials for decades; 
and in an earlier study of a4p2 receptors from this laboratory, we found that a single
exponential component fit the data fairly well under some conditions (Chamet et al.,
1991). However, the more extensive data analyzed for the present study showed (a) that 
two components fit each of several thousand relaxations better than did a single 
component; and (b) a third component added little improvement.
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What is the physical significance of the two phases? Given our uncertainty about 
the molecular events that underlie the relaxations, we cannot be certain. Nonetheless, we 
are struck by the near equality in the amplitudes of the two components over a wide range 
of [ACh] (Fig. 4, C and D). We therefore doubt that the two components describe 
interconvertible states of a single molecule. We suggest instead that the two components 
reflect distinct, non-interconvertible populations of receptors. The most straightforward, 
but admittedly daring explanation, is that (a) two neuronal nAChR pentamers reside next 
to each other in the membrane (Zingsheim, Neugebauer, Frank, Hanicke, and Barrantes, 
1982), (b) the two pentamers are slightly asymmetric, and (c) the asymmetry reveals 
itself in our kinetic experiments as a difference in gating behavior. Structural studies are 
necessary to resolve this issue.
Unresolved Issues
Several aspects of our data are unexpected on the basis of steady-state measurements.
First the EC50 for the relaxation rate constants are several fold smaller than for the 
steady-state currents. Many theories of gating allow for opening rate constants that 
continue to increase past saturation of the steady-state response; but no simple theory 
predicts that opening rates saturate at concentrations lower than steady-state responses. 
Likewise, we can offer no simple explanation for the fact that the Hill coefficients for the
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rates constants differ from those for steady-state responses: nm  is near one for a3p2 
steady-state currents and for a3|J4 rate constants, but near two for a3£4 steady-state 
currents and for a3|32 rate constants.
Acetylcholine receptor gating remains a complex but fascinating problem. For 
each region identified as important, such as the 94 to 109 region that influences 
concentration dependence, other phenomena, such as the kinetics and voltage dependence 
of the process, remain mysterious.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-31
REFERENCES
Adams, D. J., T. M. Dwyer, and B. Hille. 1980. The permeability of endplate channels 
to monovalent and divalent metal cations. Journal o f  General Physiology. 75: 
493-510.
Adams, P. R. 1975. A model for the procaine end-plate current. Journal o f  Physiology. 
246: 61p-63p.
Adams, P. R. 1981. Acetylcholine receptor kinetics. Journal o f Membrane Biology. 58: 
161-174.
Bertrand, D., A. Devillers-Thiery, F. Revah, J.-L. Galzi, N. Hussy, C. Mulle, S.
Bertrand, M. Ballivet, and J.-P. Changeux. 1992. Unconventional pharmacology 
of a neuronal nicotinic receptor mutated in the channel domain. Proceedings o f  
the National Academy o f  Sciences, USA. 89: 1261-1265.
Chamet, P., C. Labarca, R. J. Leonard, N. J. Vogelaar, L. Czyzyk, A. Gouin. N.
Davidson, and H. A. Lester. 1990. An open-channel blocker interacts with 
adjacent turns of a-helices in the nicotinic acetylcholine receptor. Neuron. 2: 
87-95.
Chamet, P., C. Labarca, B. N. Cohen, N. Davidson, H. A. Lester, and G. Pilar. 1991. 
Pharmacological and kinetic properties of a4p2 neuronal nicotinic acetylcholine 
receptors expressed in Xenopus oocytes. Journal o f  Physiology. 450: 375-394.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Cohen, B. N., A. Figl, M. W. Quick, C. Labarca, N. Davidson, and H. A. Lester. 1995. 
Regions of 32 and 34 responsible for differences between the equilibrium dose- 
response relationships of the a3p2 and a3p4 neuronal nicotinic receptors. Journal 
o f General Physiology. In press.
Doupnik, C. A., N. F. Lim, P. Kofuji, N. Davidson, and H. A. Lester. 1995.
Intrinsic gating properties of a cloned G protein-activated inward rectifier K~ 
channel. Journal o f  General Physiology. In press.
Figl, A., B. N. Cohen, M. W. Quick, N. Davidson, and H. A. Lester. 1992.
Regions of p4*p2 subunit chimeras that contribute to the agonist selectivity 
of neuronal nicotinic receptors. FEBS Letters. 308: 245-248.
Figl, A., B. N. Cohen, J. Gollub, N. Davidson, and H. A. Lester. 1993. Novel 
functional domains of the rat neuronal nicotinic subunit. Society for  
Neuroscience Abstracts. 19:8. (Abstr.)
Guastella, J. G., N. Nelson, H. Nelson, L. Czyzyk, S. Keynan, M. C. Miedel. N.
Davidson, H. A. Lester, and B. Kanner. 1990. Cloning and expression of a rat 
brain GABA transporter. Science. 249:1303-1306.
Higuchi, R. 1990. Recombinant PCR. In PCR protocols, a guide to methods and
applications. M. A. Innis, D. H. Gelfand, J. J. Sninsky and T. J. White, editors. 
Academic Press, Inc., San Diego, CA. 177-184.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-33
Ifune, C. K.., and J. H. Steinbach. 1990a. Intracellular magnesium blocks outward
current through neuronal nicotinic ACh receptor channels. Biophysical Journal. 
57: 122a. (Abstr.)
Ifune, C. K., and J. H. Steinbach. 1990b. Rectification of acetylcholine-elicited 
currents in PC 12 pheochromocytoma cells. Proceedings o f the National 
Academy o f  Sciences, USA. 87:4794-4798.
Ifune, C. K., and J. H. Steinbach. 1991. Voltage-dependent block by magnesium of 
neuronal nicotinic acetylcholine receptor channels in rat phaeochromocytoma 
cells. Journal o f  Physiology. 443:683-701.
Ifune, C. K., and J. H. Steinbach. 1992. Inward rectification of acetylcholine-elicited 
currents in rat phaeochromocytoma cells. Journal o f  Physiology. 457: 143-165.
Labarca, C., M. W. Nowak, H. Zhang, L. Tang, P. Deshpande, and H. A. Lester. 1995. 
Conserved leucine residues in the M2 domain of nicotinic receptors govern gating 
independently and symmetrically. Nature. In Press.
Lester, H. A. 1992. The permeation pathway of neurotransmitter-gated ion
channels. Annual Review o f  Biophysics and Biomolecular Structure. 21:
267-292.
Luetje, C. W., K. Wada, S. Rogers, S. N. Abramson, K. Tsuji, S. Heinemann. and J. 
Patrick. 1990. Neurotoxins distinguish between different neuronal nicotinic
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-34
acetylcholine receptor subunit combinations. Journal o f  Neurochemistry. 55: 
632-640.
Luetje, C. W., and J. Patrick. 1991. Both a- and p-subunits contribute to the agonist
sensitivity of neuronal acetylcholine receptors. The Journal o f  Neuroscience. 11: 
837-845.
Magleby, K. L., and C. F. Stevens. 1972. The effect of voltage on the time course of 
end-p late currents. Journal o f  Physiology. 223: 151-171.
Neher, E., and B. Sakmann. 1975. Voltage-dependence of drug-induced conductance in 
frog neuromuscular junction. Proceedings o f the National Academy o f  Sciences, 
USA. 72:2140-2144.
Papke, R. L., J. Boulter, J. Patrick, and S. Heinemann. 1989. Single-channel 
currents of rat neuronal nicotinic acetylcholine receptors expressed in 
Xenopus oocytes. Neuron. 3:589-596.
Papke, R. L., and S. F. Heinemann. 1991. The role of the p4 subunit in determining the 
kinetic properties of rat neuronal nicotinic acetylcholine a3 receptors. Journal o f  
Physiology. 440: 95-112.
Papke, R. L., R. M. Duvoisin, and S. F. Heinemann. 1993. The amino terminal half of 
the nicotinic-subunit extracellular domain regulates the kinetics o f inhibition by 
neuronal bungarotoxin. Proceedings o f the Royal Society o f  London B. 252: 
141-148.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Papke. R. L. 1993. The kinetic properties o f neuronal nicotinic receptors: genetic 
basis of functional diversity. Progress in Neurobiologv. 41: 509-551.
Quick, M. W., and H. A. Lester. 1994. Methods for expression of excitability
proteins in Xenopus oocytes. In Ion Channels of Excitable Cells. P. M. Conn, 
editor. Academic Press, San Diego, CA. 261-279.
Revah, F., D. Bertrand, J.-L. Galzi, A. Devillers-Thiery, C. Mulle, N. Hussy, S. Bertrand, 
M. Ballivet, and J.-P. Changeux. 1991. Mutations in the channel domain alter 
desensitization of a neuronal nicotinic receptor. Nature. 353: 846-849.
Role, L. W. 1992. Diversity in primary structure and function of neuronal
nicotinic acetylcholine receptor channels. Current Opinion in Neurobiology. 2: 
254-262.
Sands, S. B., and M. E. Barish. 1992. Neuronal nicotinic acetylcholine receptor 
currents in phaeochromocytoma (PC 12) cells: Dual mechanisms of 
rectification. Journal o f  Physiology. 447:467-487.
Sargent, P. B. 1993. The diversity of neuronal nicotinic acetylcholine receptors. Annual 
Review o f  Neuroscience. 16: 403:443.
Sheridan, R. E., and H. A. Lester. 1975. Relaxation measurements on the acetylcholine 
receptor. Proceedings o f the National Academy o f Sciences, USA. 72:
3496-3500.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-36
Sheridan, R. E., and H. A. Lester. 1977. Rates and equilibria at the acetylcholine 
receptor of Electrophorus electroplaques. A study of neurallv evoked 
postsynaptic currents and of voltage-jump relaxations. Journal o f  General 
Physiology. 70: 187-219.
Silver, M. R., and T. E. DeCoursey. 1990. Intrinsic gating of inward rectifier in bovine 
pulmonary artery endothelial cells in the presence or absence of internal Mg2+. 
Journal o f  General Physiology. 103:109-133.
Unwin, N. 1995. Acetylcholine receptor channel imaged in the open state.
Nature. 373:37-43.
Vemino, S., M. Amador, C. W. Luetje, J. Patrick, and J. A. Dani. 1992. Calcium
modulation and high calcium permeability of neuronal nicotinic acetylcholine 
receptors. Neuron. 8: 127-134.
Wong, E. T., S. Mennerick, D. B. Clifford, C. F. Zorumski, and K. E. Isenberg. 1993. 
Expression of a recombinant neuronal nicotinic acetylcholine receptor in 
transfected HEK-293 cells. Society for Neuroscience Abstracts. 19: 291.
(Abstr.)
Zingsheim, H. P., D. C. Neugebauer, J. Frank, W. Hanicke, and F. J. Barrantes. 1982.
Dimeric arrangement and structure of the membrane-bound acetylcholine receptor 
studied by electron microscopy. EMBO Journal. 1: 541-547.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C-37
Figure 1. Voltage-jump relaxations for the a3|32 fleft column) and a3p4 (right column) 
receptors expressed in oocytes at [AChj = 1 |iM. (A) Voltage-clamp currents. The 
membrane potential was held at -50 mV, jumped to a prepulse value of +50 mV for 30 
ms or 80 ms (a3p2 or a3p4, respectively), then jumped to various test potentials in the
range between -150 and -50 mV in 20 mV increments for 200 ms or 800 ms fc3p2 or 
a3p4, respectively). Agonist-induced currents have been isolated by subtracting episodes
in the absence of ACh. (B) Single and double exponential fits to the traces at -150 mV. 
The fit to a single exponential clearly deviates from the data; the fit to two exponentials 
superimposes on the data. For a3p2, xf= 16 ms; xs = 75 ms. For a3p4, Xf= 108 ms; xs = 
340 ms. (Q  Instantaneous current-voltage relations for the traces in panel (A), obtained 
by extrapolating the double-exponential fits to the time of the jump to yield Itnsl. (D ) 
Voltage dependence of the steady-state values, expressed as 7ss/ / mst-
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Figure 2. Voltage dependence of the relaxation rate constants at [ACh] = 1 (iM. Left
column, o3p2 receptor; right column, a3p4 receptor. (A) Fast rate constants, (a) Slow
rate constants. Data are mean ± SD, n = 1 to 10 oocytes. Lines represent linear 
regression fits through the data points.
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Figure 3. Availability of receptors during depolarizing prepulses. (A) a3p2 receptors.
Membrane potential was held at -50 mV and stepped to various values between +10 and 
-120 mV for 400 ms, then to the test potential of -130 mV fa  400 ms. Data have been 
multiplied by scaling factors of 1.0 to 1.12 to correct for desensitization during the trial. 
The line preceding the prepulses denotes the zero current level. (B) a3p4 receptors. The 
prepulse and test potential durations were both 2 s. (C) Average data with this protocol. 
The waveforms were fit to two exponentials, then extrapolated to the time of the jump to 
measure the instantaneous current. This instantaneous value, normalized to the steady- 
state value to account for desensitization and varying expression levels, is plotted versus 
prepulse potential. Points show mean ± SD. n = 10-14. Boltzmann relations (Eq. 2) are 
superimposed on the data.
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Figure 4. Concentration dependence of the voltage-jump kinetics. Data were acquired 
and analyzed as in Fig. 1 and pooled across all potentials between -50 and -150 mV. The 
solid lines show EC50 values of 2.3 pM and 3.1 pM for the fast and slow components of 
the a3(J2 receptor; 67 pM and 58 pM for the fast and slow components of the a3p4 
receptor; and «app values of 1.7 for both components of the a3p2 relaxations and 0.8 for 
both components of the a3(34 relaxations. (A) Fast phase of the relaxations, 1/Tf. (B) 
Slow phase, I/t s. ( Q  and (D) Fractional contribution of the fast phase expressed as 
/fast//tot. Points show mean ± SD. n = 2 to 10 oocytes for each point.
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Figure 5. Sequence alignment of neuronal nicotinic [32 and |34 subunits. The putative 
transmembrane regions M1-M4 are underlined. The arrows indicate the transition point 
of the (34 NTT-terminal chimeras. The residue preceding the arrow is the last amino acid 
included from (34. Note the single difference in the M2 transmembrane segments.
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Figure 6. Kinetic data for a series of chimeric p subunits. (A) Fast and (B) Slow voltage- 
jump relaxations, analyzed and presented as for the wild-type receptors (Fig. 4). The 
dose-response relations for the wild type a3p2 receptor are superimposed on the data as
solid lines (mean) and dashed lines (± SD) n = 2 to 10 oocytes per point for the chimeras. 
(C) and (D) Subtracted and normalized data, as described in the text. Solid lines are 
fitted dose-response relations for the individual receptors; dashed lines are fitted data for 
a3p2 and a3p4 wild-type receptors. Legend in (A) applies to all panels.
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Figure 7. Voltage dependence for several chimeric (34/p2 receptors, as well as for the
wild-type j}4 and (52 subunits, expressed with the a3 subunit. Analyses as in the
experiment of Fig. 1. Data have been pooled from concentrations ranging from 1 to 3 
jiM ACh. Data are averages of 2 to 10 cells per point. SEM's are shown where they 
exceed the size of the symbols.
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Figure 8. Voltage-jump relaxations for a4(34 receptors. Rate constants are plotted versus 
[ACh], as in Fig. 4. (A) Exemplar traces of a3p4 relaxations at 2 jiM ACh. After a 50 ms 
prepulse at +50 mV, a series of six 400 ms test pulses were applied between -120 and -70 
mV in 10 mV increments. The line preceding the prepulse denotes the zero current level.
(B) Traces for a3p4 relaxations at 2 pM ACh. After a 50 ms prepulse at +50 mV, the
voltages were stepped as in panel (A) for 800 ms. Note the difference in horizontal 
calibration. (C) and (D) Concentration dependence of the fast and slow relaxation 
components of a4|34 receptors. Points show mean ± SD (n = 3 to 6 cells). The data are 
superimposed on the solid lines and dashed lines summarizing the dose-response relation 
for a3p2 receptors (mean and ± SD, respectively).
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